COHESIN LOADING ONTO CHROMATIN
|
10
|
3.53e-03
|
-5.33e-01
|
0.060700
|
SYNTHESIS SECRETION AND INACTIVATION OF GLUCAGON LIKE PEPTIDE 1 GLP 1
|
12
|
1.40e-03
|
-5.33e-01
|
0.038200
|
INCRETIN SYNTHESIS SECRETION AND INACTIVATION
|
13
|
1.18e-03
|
-5.20e-01
|
0.037000
|
POST CHAPERONIN TUBULIN FOLDING PATHWAY
|
17
|
2.64e-04
|
5.11e-01
|
0.017300
|
CROSSLINKING OF COLLAGEN FIBRILS
|
15
|
9.33e-04
|
4.94e-01
|
0.036900
|
TERMINATION OF O GLYCAN BIOSYNTHESIS
|
11
|
5.19e-03
|
4.87e-01
|
0.077500
|
PROCESSING AND ACTIVATION OF SUMO
|
10
|
8.21e-03
|
-4.83e-01
|
0.101000
|
APOPTOSIS INDUCED DNA FRAGMENTATION
|
10
|
8.22e-03
|
-4.83e-01
|
0.101000
|
ADENYLATE CYCLASE ACTIVATING PATHWAY
|
10
|
1.06e-02
|
4.67e-01
|
0.110000
|
TRANSPORT OF CONNEXONS TO THE PLASMA MEMBRANE
|
13
|
4.40e-03
|
4.56e-01
|
0.068600
|
SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN
|
12
|
6.28e-03
|
-4.56e-01
|
0.086400
|
CYTOSOLIC IRON SULFUR CLUSTER ASSEMBLY
|
13
|
5.32e-03
|
4.46e-01
|
0.077800
|
CD28 DEPENDENT VAV1 PATHWAY
|
11
|
1.14e-02
|
-4.41e-01
|
0.113000
|
ACTIVATION OF SMO
|
16
|
2.79e-03
|
4.32e-01
|
0.055300
|
MITOTIC TELOPHASE CYTOKINESIS
|
13
|
1.12e-02
|
-4.06e-01
|
0.112000
|
SYNTHESIS OF ACTIVE UBIQUITIN ROLES OF E1 AND E2 ENZYMES
|
29
|
1.73e-04
|
-4.03e-01
|
0.014500
|
MET ACTIVATES RAP1 AND RAC1
|
11
|
2.26e-02
|
-3.97e-01
|
0.165000
|
REPRESSION OF WNT TARGET GENES
|
14
|
1.16e-02
|
3.89e-01
|
0.113000
|
CREB1 PHOSPHORYLATION THROUGH THE ACTIVATION OF ADENYLATE CYCLASE
|
11
|
2.67e-02
|
-3.86e-01
|
0.181000
|
CHK1 CHK2 CDS1 MEDIATED INACTIVATION OF CYCLIN B CDK1 COMPLEX
|
10
|
3.52e-02
|
-3.85e-01
|
0.219000
|
CELLULAR HEXOSE TRANSPORT
|
11
|
2.92e-02
|
3.80e-01
|
0.193000
|
ACTIVATION OF RAC1
|
13
|
1.81e-02
|
-3.78e-01
|
0.144000
|
ACTIVATION OF AMPK DOWNSTREAM OF NMDARS
|
20
|
4.30e-03
|
3.69e-01
|
0.068600
|
SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION
|
14
|
1.81e-02
|
3.65e-01
|
0.144000
|
SYNAPTIC ADHESION LIKE MOLECULES
|
21
|
4.08e-03
|
3.62e-01
|
0.067200
|
ASSEMBLY AND CELL SURFACE PRESENTATION OF NMDA RECEPTORS
|
35
|
2.80e-04
|
3.55e-01
|
0.017300
|
FOXO MEDIATED TRANSCRIPTION OF CELL DEATH GENES
|
15
|
1.86e-02
|
3.51e-01
|
0.146000
|
NRAGE SIGNALS DEATH THROUGH JNK
|
55
|
8.21e-06
|
3.48e-01
|
0.002010
|
SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS
|
20
|
7.28e-03
|
-3.47e-01
|
0.096800
|
A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS
|
26
|
2.31e-03
|
3.45e-01
|
0.049700
|
MATURATION OF NUCLEOPROTEIN
|
10
|
5.99e-02
|
-3.44e-01
|
0.290000
|
EARLY PHASE OF HIV LIFE CYCLE
|
13
|
3.38e-02
|
-3.40e-01
|
0.213000
|
SIGNALING BY FGFR4 IN DISEASE
|
10
|
6.56e-02
|
-3.36e-01
|
0.304000
|
PRE NOTCH PROCESSING IN GOLGI
|
18
|
1.38e-02
|
3.35e-01
|
0.127000
|
SIGNALING BY FGFR3 FUSIONS IN CANCER
|
10
|
6.99e-02
|
-3.31e-01
|
0.308000
|
E2F MEDIATED REGULATION OF DNA REPLICATION
|
19
|
1.37e-02
|
-3.27e-01
|
0.127000
|
COLLAGEN BIOSYNTHESIS AND MODIFYING ENZYMES
|
62
|
9.19e-06
|
3.26e-01
|
0.002010
|
SYNTHESIS OF LEUKOTRIENES LT AND EOXINS EX
|
12
|
5.22e-02
|
3.24e-01
|
0.278000
|
CARBOXYTERMINAL POST TRANSLATIONAL MODIFICATIONS OF TUBULIN
|
35
|
9.78e-04
|
3.22e-01
|
0.036900
|
SEALING OF THE NUCLEAR ENVELOPE NE BY ESCRT III
|
23
|
7.57e-03
|
3.22e-01
|
0.098500
|
NOTCH4 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION
|
20
|
1.30e-02
|
3.21e-01
|
0.121000
|
CRMPS IN SEMA3A SIGNALING
|
16
|
2.65e-02
|
3.20e-01
|
0.181000
|
ADP SIGNALLING THROUGH P2Y PURINOCEPTOR 12
|
19
|
1.72e-02
|
-3.16e-01
|
0.143000
|
NCAM1 INTERACTIONS
|
40
|
6.34e-04
|
3.12e-01
|
0.031000
|
PEXOPHAGY
|
11
|
8.01e-02
|
3.05e-01
|
0.334000
|
REGULATION OF TP53 ACTIVITY THROUGH ASSOCIATION WITH CO FACTORS
|
13
|
5.74e-02
|
3.04e-01
|
0.287000
|
INSULIN PROCESSING
|
24
|
9.89e-03
|
-3.04e-01
|
0.109000
|
PRESYNAPTIC DEPOLARIZATION AND CALCIUM CHANNEL OPENING
|
11
|
8.21e-02
|
3.03e-01
|
0.337000
|
G BETA GAMMA SIGNALLING THROUGH CDC42
|
18
|
2.63e-02
|
-3.03e-01
|
0.181000
|
NF KB IS ACTIVATED AND SIGNALS SURVIVAL
|
13
|
5.90e-02
|
3.02e-01
|
0.288000
|
SYNTHESIS OF IP3 AND IP4 IN THE CYTOSOL
|
26
|
7.61e-03
|
3.02e-01
|
0.098500
|
MET ACTIVATES RAS SIGNALING
|
10
|
9.87e-02
|
-3.02e-01
|
0.371000
|
CLEC7A DECTIN 1 INDUCES NFAT ACTIVATION
|
11
|
8.35e-02
|
-3.01e-01
|
0.339000
|
SIGNALING BY PDGFRA TRANSMEMBRANE JUXTAMEMBRANE AND KINASE DOMAIN MUTANTS
|
12
|
7.41e-02
|
-2.98e-01
|
0.313000
|
PROTEIN UBIQUITINATION
|
69
|
2.04e-05
|
-2.97e-01
|
0.002390
|
GENE AND PROTEIN EXPRESSION BY JAK STAT SIGNALING AFTER INTERLEUKIN 12 STIMULATION
|
31
|
4.31e-03
|
-2.96e-01
|
0.068600
|
DEFECTIVE B4GALT7 CAUSES EDS PROGEROID TYPE
|
20
|
2.22e-02
|
2.95e-01
|
0.165000
|
TNF RECEPTOR SUPERFAMILY TNFSF MEMBERS MEDIATING NON CANONICAL NF KB PATHWAY
|
13
|
6.67e-02
|
2.94e-01
|
0.305000
|
REGULATION OF COMMISSURAL AXON PATHFINDING BY SLIT AND ROBO
|
10
|
1.08e-01
|
2.94e-01
|
0.384000
|
RUNX3 REGULATES NOTCH SIGNALING
|
13
|
6.73e-02
|
2.93e-01
|
0.305000
|
RHO GTPASES ACTIVATE IQGAPS
|
23
|
1.50e-02
|
2.93e-01
|
0.135000
|
GAP JUNCTION ASSEMBLY
|
22
|
1.76e-02
|
2.92e-01
|
0.144000
|
LGI ADAM INTERACTIONS
|
14
|
6.08e-02
|
2.89e-01
|
0.291000
|
RETROGRADE NEUROTROPHIN SIGNALLING
|
13
|
7.09e-02
|
2.89e-01
|
0.310000
|
COLLAGEN FORMATION
|
78
|
1.03e-05
|
2.89e-01
|
0.002010
|
REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX
|
15
|
5.35e-02
|
-2.88e-01
|
0.278000
|
SIGNALING BY NOTCH1 HD DOMAIN MUTANTS IN CANCER
|
15
|
5.36e-02
|
2.88e-01
|
0.278000
|
ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC
|
23
|
1.70e-02
|
-2.88e-01
|
0.143000
|
SIGNALING BY FLT3 FUSION PROTEINS
|
18
|
3.54e-02
|
-2.86e-01
|
0.219000
|
RMTS METHYLATE HISTONE ARGININES
|
43
|
1.18e-03
|
2.86e-01
|
0.037000
|
NOTCH HLH TRANSCRIPTION PATHWAY
|
28
|
9.67e-03
|
2.83e-01
|
0.109000
|
REGULATION OF RUNX1 EXPRESSION AND ACTIVITY
|
17
|
4.60e-02
|
2.80e-01
|
0.261000
|
RHOBTB1 GTPASE CYCLE
|
23
|
2.09e-02
|
-2.78e-01
|
0.157000
|
REGULATION OF GENE EXPRESSION IN LATE STAGE BRANCHING MORPHOGENESIS PANCREATIC BUD PRECURSOR CELLS
|
13
|
8.28e-02
|
2.78e-01
|
0.339000
|
INTERLEUKIN 37 SIGNALING
|
17
|
4.84e-02
|
2.77e-01
|
0.266000
|
SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE
|
20
|
3.25e-02
|
2.76e-01
|
0.209000
|
DISEASES ASSOCIATED WITH O GLYCOSYLATION OF PROTEINS
|
54
|
5.00e-04
|
2.74e-01
|
0.029300
|
RECYCLING PATHWAY OF L1
|
40
|
2.86e-03
|
2.73e-01
|
0.055700
|
KINESINS
|
48
|
1.10e-03
|
2.72e-01
|
0.037000
|
DISEASES ASSOCIATED WITH GLYCOSYLATION PRECURSOR BIOSYNTHESIS
|
18
|
4.55e-02
|
2.72e-01
|
0.261000
|
ADENYLATE CYCLASE INHIBITORY PATHWAY
|
13
|
8.99e-02
|
2.72e-01
|
0.354000
|
PROTEIN METHYLATION
|
17
|
5.41e-02
|
-2.70e-01
|
0.278000
|
E3 UBIQUITIN LIGASES UBIQUITINATE TARGET PROTEINS
|
50
|
9.79e-04
|
-2.70e-01
|
0.036900
|
PHASE 2 PLATEAU PHASE
|
13
|
9.29e-02
|
2.69e-01
|
0.356000
|
REGULATION OF INNATE IMMUNE RESPONSES TO CYTOSOLIC DNA
|
13
|
9.31e-02
|
2.69e-01
|
0.356000
|
IRE1ALPHA ACTIVATES CHAPERONES
|
49
|
1.20e-03
|
2.68e-01
|
0.037000
|
COLLAGEN CHAIN TRIMERIZATION
|
39
|
4.01e-03
|
2.66e-01
|
0.067100
|
CARNITINE METABOLISM
|
14
|
8.91e-02
|
2.62e-01
|
0.354000
|
METHYLATION
|
11
|
1.35e-01
|
-2.60e-01
|
0.432000
|
COOPERATION OF PDCL PHLP1 AND TRIC CCT IN G PROTEIN BETA FOLDING
|
35
|
7.74e-03
|
-2.60e-01
|
0.098500
|
TP53 REGULATES TRANSCRIPTION OF GENES INVOLVED IN G2 CELL CYCLE ARREST
|
15
|
8.12e-02
|
2.60e-01
|
0.336000
|
TRIGLYCERIDE CATABOLISM
|
14
|
9.32e-02
|
-2.59e-01
|
0.356000
|
CELL EXTRACELLULAR MATRIX INTERACTIONS
|
18
|
5.84e-02
|
2.58e-01
|
0.287000
|
DOWNREGULATION OF ERBB2 ERBB3 SIGNALING
|
13
|
1.11e-01
|
2.55e-01
|
0.387000
|
GAP JUNCTION TRAFFICKING AND REGULATION
|
34
|
1.07e-02
|
2.53e-01
|
0.110000
|
REGULATION OF TLR BY ENDOGENOUS LIGAND
|
12
|
1.30e-01
|
-2.52e-01
|
0.422000
|
ANCHORING FIBRIL FORMATION
|
14
|
1.02e-01
|
2.52e-01
|
0.377000
|
CLASS I PEROXISOMAL MEMBRANE PROTEIN IMPORT
|
20
|
5.22e-02
|
-2.51e-01
|
0.278000
|
CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE
|
73
|
2.27e-04
|
2.50e-01
|
0.017300
|
VLDLR INTERNALISATION AND DEGRADATION
|
12
|
1.35e-01
|
2.49e-01
|
0.432000
|
PEPTIDE HORMONE METABOLISM
|
58
|
1.06e-03
|
-2.49e-01
|
0.037000
|
HSF1 DEPENDENT TRANSACTIVATION
|
35
|
1.11e-02
|
2.48e-01
|
0.111000
|
SIGNALING BY LEPTIN
|
10
|
1.78e-01
|
2.46e-01
|
0.482000
|
NEGATIVE REGULATION OF TCF DEPENDENT SIGNALING BY WNT LIGAND ANTAGONISTS
|
10
|
1.80e-01
|
2.45e-01
|
0.484000
|
PYRUVATE METABOLISM
|
27
|
2.86e-02
|
-2.43e-01
|
0.192000
|
GLUCONEOGENESIS
|
27
|
2.89e-02
|
2.43e-01
|
0.193000
|
INTERLEUKIN 12 SIGNALING
|
37
|
1.07e-02
|
-2.43e-01
|
0.110000
|
SIGNALING BY BMP
|
24
|
4.10e-02
|
-2.41e-01
|
0.243000
|
CYTOCHROME C MEDIATED APOPTOTIC RESPONSE
|
12
|
1.49e-01
|
-2.41e-01
|
0.452000
|
CONSTITUTIVE SIGNALING BY OVEREXPRESSED ERBB2
|
11
|
1.68e-01
|
-2.40e-01
|
0.475000
|
ASSEMBLY OF COLLAGEN FIBRILS AND OTHER MULTIMERIC STRUCTURES
|
51
|
3.07e-03
|
2.40e-01
|
0.057500
|
BIOTIN TRANSPORT AND METABOLISM
|
11
|
1.71e-01
|
2.39e-01
|
0.475000
|
RHOBTB3 ATPASE CYCLE
|
10
|
1.96e-01
|
-2.36e-01
|
0.506000
|
RESOLUTION OF D LOOP STRUCTURES THROUGH SYNTHESIS DEPENDENT STRAND ANNEALING SDSA
|
24
|
4.51e-02
|
-2.36e-01
|
0.261000
|
BRANCHED CHAIN AMINO ACID CATABOLISM
|
21
|
6.09e-02
|
-2.36e-01
|
0.291000
|
NCAM SIGNALING FOR NEURITE OUT GROWTH
|
60
|
1.67e-03
|
2.35e-01
|
0.042400
|
SHC MEDIATED CASCADE FGFR4
|
11
|
1.79e-01
|
-2.34e-01
|
0.484000
|
ZBP1 DAI MEDIATED INDUCTION OF TYPE I IFNS
|
18
|
8.59e-02
|
2.34e-01
|
0.344000
|
REGULATION OF BETA CELL DEVELOPMENT
|
24
|
4.77e-02
|
2.33e-01
|
0.265000
|
KERATAN SULFATE BIOSYNTHESIS
|
23
|
5.31e-02
|
2.33e-01
|
0.278000
|
REGULATION OF IFNG SIGNALING
|
13
|
1.48e-01
|
-2.31e-01
|
0.452000
|
ELEVATION OF CYTOSOLIC CA2 LEVELS
|
15
|
1.21e-01
|
2.31e-01
|
0.411000
|
NOTCH3 ACTIVATION AND TRANSMISSION OF SIGNAL TO THE NUCLEUS
|
26
|
4.23e-02
|
2.30e-01
|
0.248000
|
CDC42 GTPASE CYCLE
|
152
|
9.93e-07
|
2.30e-01
|
0.000581
|
WNT5A DEPENDENT INTERNALIZATION OF FZD4
|
15
|
1.23e-01
|
2.30e-01
|
0.413000
|
THE PHOTOTRANSDUCTION CASCADE
|
21
|
6.86e-02
|
-2.30e-01
|
0.307000
|
O GLYCOSYLATION OF TSR DOMAIN CONTAINING PROTEINS
|
37
|
1.58e-02
|
2.29e-01
|
0.138000
|
NOTCH2 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION
|
11
|
1.88e-01
|
2.29e-01
|
0.495000
|
ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS
|
32
|
2.48e-02
|
2.29e-01
|
0.175000
|
P75NTR SIGNALS VIA NF KB
|
16
|
1.13e-01
|
2.29e-01
|
0.392000
|
AKT PHOSPHORYLATES TARGETS IN THE NUCLEUS
|
10
|
2.11e-01
|
2.29e-01
|
0.523000
|
CGMP EFFECTS
|
15
|
1.25e-01
|
-2.29e-01
|
0.415000
|
INTERACTION BETWEEN L1 AND ANKYRINS
|
27
|
4.00e-02
|
2.28e-01
|
0.241000
|
P75 NTR RECEPTOR MEDIATED SIGNALLING
|
94
|
1.39e-04
|
2.27e-01
|
0.012500
|
AGGREPHAGY
|
34
|
2.20e-02
|
2.27e-01
|
0.164000
|
CONSTITUTIVE SIGNALING BY AKT1 E17K IN CANCER
|
26
|
4.58e-02
|
2.26e-01
|
0.261000
|
DARPP 32 EVENTS
|
23
|
6.05e-02
|
-2.26e-01
|
0.291000
|
TIE2 SIGNALING
|
17
|
1.07e-01
|
-2.26e-01
|
0.384000
|
PHOSPHORYLATION OF THE APC C
|
17
|
1.09e-01
|
-2.25e-01
|
0.384000
|
ACTIVATED NTRK2 SIGNALS THROUGH FRS2 AND FRS3
|
10
|
2.20e-01
|
-2.24e-01
|
0.534000
|
IRF3 MEDIATED INDUCTION OF TYPE I IFN
|
11
|
2.00e-01
|
2.23e-01
|
0.512000
|
ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING
|
11
|
2.00e-01
|
-2.23e-01
|
0.512000
|
ROLE OF PHOSPHOLIPIDS IN PHAGOCYTOSIS
|
22
|
7.11e-02
|
2.22e-01
|
0.310000
|
METABOLISM OF POLYAMINES
|
58
|
3.47e-03
|
-2.22e-01
|
0.060700
|
DEADENYLATION OF MRNA
|
25
|
5.50e-02
|
-2.22e-01
|
0.280000
|
PI 3K CASCADE FGFR4
|
11
|
2.03e-01
|
-2.22e-01
|
0.516000
|
TRISTETRAPROLIN TTP ZFP36 BINDS AND DESTABILIZES MRNA
|
16
|
1.25e-01
|
-2.21e-01
|
0.415000
|
DISEASES OF GLYCOSYLATION
|
127
|
1.73e-05
|
2.21e-01
|
0.002250
|
DEFECTIVE EXT2 CAUSES EXOSTOSES 2
|
14
|
1.54e-01
|
2.20e-01
|
0.460000
|
SIGNALLING TO RAS
|
18
|
1.06e-01
|
2.20e-01
|
0.383000
|
IRAK4 DEFICIENCY TLR2 4
|
13
|
1.71e-01
|
-2.19e-01
|
0.475000
|
SEMA4D IN SEMAPHORIN SIGNALING
|
24
|
6.54e-02
|
2.17e-01
|
0.304000
|
HOMOLOGOUS DNA PAIRING AND STRAND EXCHANGE
|
40
|
1.75e-02
|
-2.17e-01
|
0.144000
|
INHIBITION OF THE PROTEOLYTIC ACTIVITY OF APC C REQUIRED FOR THE ONSET OF ANAPHASE BY MITOTIC SPINDLE CHECKPOINT COMPONENTS
|
19
|
1.03e-01
|
-2.16e-01
|
0.377000
|
G ALPHA 12 13 SIGNALLING EVENTS
|
74
|
1.37e-03
|
2.15e-01
|
0.038200
|
ABERRANT REGULATION OF MITOTIC EXIT IN CANCER DUE TO RB1 DEFECTS
|
19
|
1.06e-01
|
-2.14e-01
|
0.383000
|
SIGNALING BY PDGFR IN DISEASE
|
20
|
9.81e-02
|
-2.14e-01
|
0.370000
|
ECM PROTEOGLYCANS
|
66
|
2.74e-03
|
2.13e-01
|
0.055200
|
DEFECTIVE CFTR CAUSES CYSTIC FIBROSIS
|
59
|
4.71e-03
|
-2.13e-01
|
0.072500
|
REGULATION OF BACH1 ACTIVITY
|
11
|
2.22e-01
|
-2.13e-01
|
0.535000
|
KERATAN SULFATE KERATIN METABOLISM
|
29
|
4.81e-02
|
2.12e-01
|
0.265000
|
OLFACTORY SIGNALING PATHWAY
|
30
|
4.47e-02
|
-2.12e-01
|
0.260000
|
ACTIVATION OF BAD AND TRANSLOCATION TO MITOCHONDRIA
|
15
|
1.56e-01
|
-2.12e-01
|
0.462000
|
REGULATION OF TP53 ACTIVITY THROUGH METHYLATION
|
18
|
1.21e-01
|
2.11e-01
|
0.411000
|
CHONDROITIN SULFATE BIOSYNTHESIS
|
19
|
1.11e-01
|
2.11e-01
|
0.387000
|
RAB GERANYLGERANYLATION
|
59
|
5.05e-03
|
-2.11e-01
|
0.076700
|
LAMININ INTERACTIONS
|
28
|
5.33e-02
|
2.11e-01
|
0.278000
|
INTERLEUKIN 10 SIGNALING
|
20
|
1.03e-01
|
-2.11e-01
|
0.377000
|
INTERLEUKIN 20 FAMILY SIGNALING
|
13
|
1.89e-01
|
2.11e-01
|
0.495000
|
INITIAL TRIGGERING OF COMPLEMENT
|
11
|
2.27e-01
|
2.10e-01
|
0.545000
|
TICAM1 RIP1 MEDIATED IKK COMPLEX RECRUITMENT
|
18
|
1.23e-01
|
-2.10e-01
|
0.413000
|
NEGATIVE REGULATION OF NMDA RECEPTOR MEDIATED NEURONAL TRANSMISSION
|
21
|
9.64e-02
|
2.10e-01
|
0.366000
|
PURINE CATABOLISM
|
16
|
1.49e-01
|
-2.09e-01
|
0.452000
|
ACTIVATION OF THE MRNA UPON BINDING OF THE CAP BINDING COMPLEX AND EIFS AND SUBSEQUENT BINDING TO 43S
|
59
|
5.60e-03
|
-2.09e-01
|
0.080900
|
RHOBTB GTPASE CYCLE
|
35
|
3.28e-02
|
-2.08e-01
|
0.210000
|
SIGNALING BY CTNNB1 PHOSPHO SITE MUTANTS
|
15
|
1.63e-01
|
-2.08e-01
|
0.468000
|
RHOBTB2 GTPASE CYCLE
|
23
|
8.47e-02
|
-2.08e-01
|
0.343000
|
BBSOME MEDIATED CARGO TARGETING TO CILIUM
|
23
|
8.55e-02
|
-2.07e-01
|
0.344000
|
SYNTHESIS OF PE
|
13
|
1.99e-01
|
2.06e-01
|
0.512000
|
ORC1 REMOVAL FROM CHROMATIN
|
68
|
3.52e-03
|
-2.05e-01
|
0.060700
|
ELASTIC FIBRE FORMATION
|
36
|
3.42e-02
|
2.04e-01
|
0.215000
|
DEGRADATION OF THE EXTRACELLULAR MATRIX
|
107
|
2.71e-04
|
2.04e-01
|
0.017300
|
ANTIGEN PROCESSING CROSS PRESENTATION
|
95
|
6.36e-04
|
-2.03e-01
|
0.031000
|
NEGATIVE REGULATION OF NOTCH4 SIGNALING
|
54
|
1.01e-02
|
-2.02e-01
|
0.110000
|
PYROPTOSIS
|
21
|
1.09e-01
|
-2.02e-01
|
0.384000
|
SWITCHING OF ORIGINS TO A POST REPLICATIVE STATE
|
87
|
1.18e-03
|
-2.01e-01
|
0.037000
|
SUMOYLATION OF INTRACELLULAR RECEPTORS
|
25
|
8.17e-02
|
-2.01e-01
|
0.337000
|
S PHASE
|
155
|
1.60e-05
|
-2.01e-01
|
0.002250
|
INTRINSIC PATHWAY OF FIBRIN CLOT FORMATION
|
12
|
2.29e-01
|
-2.01e-01
|
0.547000
|
CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES
|
47
|
1.79e-02
|
-2.00e-01
|
0.144000
|
REGULATION OF RUNX2 EXPRESSION AND ACTIVITY
|
70
|
3.90e-03
|
-2.00e-01
|
0.066100
|
INTERFERON ALPHA BETA SIGNALING
|
52
|
1.29e-02
|
-1.99e-01
|
0.121000
|
SEROTONIN NEUROTRANSMITTER RELEASE CYCLE
|
18
|
1.44e-01
|
1.99e-01
|
0.443000
|
PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR
|
16
|
1.68e-01
|
-1.99e-01
|
0.475000
|
PLATELET AGGREGATION PLUG FORMATION
|
32
|
5.14e-02
|
1.99e-01
|
0.277000
|
NOTCH2 ACTIVATION AND TRANSMISSION OF SIGNAL TO THE NUCLEUS
|
23
|
9.99e-02
|
1.98e-01
|
0.375000
|
DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR
|
79
|
2.34e-03
|
-1.98e-01
|
0.049700
|
PRE NOTCH EXPRESSION AND PROCESSING
|
64
|
6.18e-03
|
1.98e-01
|
0.086100
|
TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR
|
11
|
2.57e-01
|
-1.97e-01
|
0.580000
|
NITRIC OXIDE STIMULATES GUANYLATE CYCLASE
|
20
|
1.27e-01
|
-1.97e-01
|
0.417000
|
FORMATION OF FIBRIN CLOT CLOTTING CASCADE
|
20
|
1.28e-01
|
-1.97e-01
|
0.418000
|
NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION
|
11
|
2.61e-01
|
-1.96e-01
|
0.585000
|
INTERLEUKIN 12 FAMILY SIGNALING
|
44
|
2.46e-02
|
-1.96e-01
|
0.175000
|
CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM
|
49
|
1.81e-02
|
1.95e-01
|
0.144000
|
FATTY ACYL COA BIOSYNTHESIS
|
32
|
5.77e-02
|
-1.94e-01
|
0.287000
|
DISEASES ASSOCIATED WITH GLYCOSAMINOGLYCAN METABOLISM
|
39
|
3.69e-02
|
1.93e-01
|
0.226000
|
O LINKED GLYCOSYLATION
|
89
|
1.66e-03
|
1.93e-01
|
0.042400
|
PROCESSING OF SMDT1
|
16
|
1.82e-01
|
-1.93e-01
|
0.487000
|
FORMATION OF THE BETA CATENIN TCF TRANSACTIVATING COMPLEX
|
46
|
2.39e-02
|
1.93e-01
|
0.172000
|
SCF SKP2 MEDIATED DEGRADATION OF P27 P21
|
59
|
1.08e-02
|
-1.92e-01
|
0.110000
|
CHOLESTEROL BIOSYNTHESIS
|
24
|
1.04e-01
|
-1.92e-01
|
0.380000
|
GLYCOGEN SYNTHESIS
|
14
|
2.14e-01
|
-1.92e-01
|
0.526000
|
EXTRACELLULAR MATRIX ORGANIZATION
|
241
|
3.09e-07
|
1.92e-01
|
0.000362
|
INTEGRIN SIGNALING
|
24
|
1.05e-01
|
1.91e-01
|
0.382000
|
SIGNALING BY NOTCH2
|
33
|
5.80e-02
|
1.91e-01
|
0.287000
|
NEGATIVE REGULATORS OF DDX58 IFIH1 SIGNALING
|
32
|
6.24e-02
|
-1.90e-01
|
0.296000
|
APC C MEDIATED DEGRADATION OF CELL CYCLE PROTEINS
|
81
|
3.08e-03
|
-1.90e-01
|
0.057500
|
HYALURONAN METABOLISM
|
15
|
2.02e-01
|
1.90e-01
|
0.515000
|
TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES
|
31
|
6.77e-02
|
1.90e-01
|
0.306000
|
GLUTAMATE AND GLUTAMINE METABOLISM
|
13
|
2.39e-01
|
1.89e-01
|
0.561000
|
SIGNALING BY FLT3 ITD AND TKD MUTANTS
|
15
|
2.06e-01
|
-1.89e-01
|
0.520000
|
DNA DAMAGE BYPASS
|
47
|
2.56e-02
|
-1.88e-01
|
0.178000
|
RAF INDEPENDENT MAPK1 3 ACTIVATION
|
21
|
1.36e-01
|
1.88e-01
|
0.433000
|
HDACS DEACETYLATE HISTONES
|
46
|
2.77e-02
|
1.88e-01
|
0.187000
|
COLLAGEN DEGRADATION
|
51
|
2.05e-02
|
1.88e-01
|
0.157000
|
ABORTIVE ELONGATION OF HIV 1 TRANSCRIPT IN THE ABSENCE OF TAT
|
23
|
1.20e-01
|
1.88e-01
|
0.410000
|
STABILIZATION OF P53
|
55
|
1.68e-02
|
-1.87e-01
|
0.143000
|
TRANSLESION SYNTHESIS BY POLH
|
19
|
1.60e-01
|
-1.86e-01
|
0.465000
|
ASPARTATE AND ASPARAGINE METABOLISM
|
10
|
3.07e-01
|
-1.86e-01
|
0.647000
|
FRS MEDIATED FGFR4 SIGNALING
|
13
|
2.45e-01
|
-1.86e-01
|
0.566000
|
RIP MEDIATED NFKB ACTIVATION VIA ZBP1
|
15
|
2.12e-01
|
1.86e-01
|
0.525000
|
SIGNALING BY FGFR1 IN DISEASE
|
32
|
6.92e-02
|
-1.86e-01
|
0.307000
|
ASSEMBLY OF THE PRE REPLICATIVE COMPLEX
|
65
|
9.82e-03
|
-1.85e-01
|
0.109000
|
PKA ACTIVATION IN GLUCAGON SIGNALLING
|
16
|
2.00e-01
|
1.85e-01
|
0.512000
|
GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION
|
31
|
7.44e-02
|
1.85e-01
|
0.313000
|
TRP CHANNELS
|
18
|
1.75e-01
|
1.84e-01
|
0.480000
|
SIGNALING BY KIT IN DISEASE
|
20
|
1.55e-01
|
-1.84e-01
|
0.462000
|
SIGNALING BY ERBB2 ECD MUTANTS
|
16
|
2.04e-01
|
-1.83e-01
|
0.517000
|
INTERFERON GAMMA SIGNALING
|
73
|
6.82e-03
|
-1.83e-01
|
0.092700
|
G2 M DNA DAMAGE CHECKPOINT
|
65
|
1.07e-02
|
-1.83e-01
|
0.110000
|
NR1H3 NR1H2 REGULATE GENE EXPRESSION LINKED TO CHOLESTEROL TRANSPORT AND EFFLUX
|
32
|
7.31e-02
|
1.83e-01
|
0.311000
|
INOSITOL PHOSPHATE METABOLISM
|
47
|
3.03e-02
|
1.83e-01
|
0.198000
|
P75NTR RECRUITS SIGNALLING COMPLEXES
|
13
|
2.54e-01
|
1.83e-01
|
0.580000
|
RET SIGNALING
|
36
|
5.83e-02
|
1.82e-01
|
0.287000
|
ACTIVATION OF THE PRE REPLICATIVE COMPLEX
|
30
|
8.49e-02
|
-1.82e-01
|
0.343000
|
AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE
|
26
|
1.10e-01
|
1.81e-01
|
0.385000
|
GP1B IX V ACTIVATION SIGNALLING
|
10
|
3.22e-01
|
1.81e-01
|
0.661000
|
FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION
|
120
|
6.36e-04
|
1.81e-01
|
0.031000
|
RHOB GTPASE CYCLE
|
67
|
1.08e-02
|
1.80e-01
|
0.110000
|
DEGRADATION OF CYSTEINE AND HOMOCYSTEINE
|
12
|
2.82e-01
|
1.79e-01
|
0.617000
|
SIGNALING BY HIPPO
|
20
|
1.65e-01
|
-1.79e-01
|
0.472000
|
TRANSLESION SYNTHESIS BY POLK
|
17
|
2.01e-01
|
-1.79e-01
|
0.513000
|
MITOTIC SPINDLE CHECKPOINT
|
96
|
2.45e-03
|
-1.79e-01
|
0.051300
|
DISEASES OF METABOLISM
|
201
|
1.24e-05
|
1.79e-01
|
0.002080
|
RECOGNITION OF DNA DAMAGE BY PCNA CONTAINING REPLICATION COMPLEX
|
30
|
9.02e-02
|
-1.79e-01
|
0.354000
|
ORGANIC CATION ANION ZWITTERION TRANSPORT
|
10
|
3.28e-01
|
1.78e-01
|
0.667000
|
ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS
|
34
|
7.19e-02
|
-1.78e-01
|
0.311000
|
MITOCHONDRIAL TRNA AMINOACYLATION
|
21
|
1.61e-01
|
1.77e-01
|
0.466000
|
FGFR1 MUTANT RECEPTOR ACTIVATION
|
25
|
1.27e-01
|
-1.76e-01
|
0.417000
|
INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES
|
29
|
1.01e-01
|
-1.76e-01
|
0.375000
|
REGULATION OF HMOX1 EXPRESSION AND ACTIVITY
|
64
|
1.52e-02
|
-1.76e-01
|
0.135000
|
ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE
|
15
|
2.41e-01
|
1.75e-01
|
0.562000
|
COMMON PATHWAY OF FIBRIN CLOT FORMATION
|
11
|
3.15e-01
|
-1.75e-01
|
0.654000
|
RUNX1 REGULATES GENES INVOLVED IN MEGAKARYOCYTE DIFFERENTIATION AND PLATELET FUNCTION
|
50
|
3.24e-02
|
1.75e-01
|
0.209000
|
SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE
|
106
|
1.89e-03
|
-1.75e-01
|
0.043300
|
APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1
|
70
|
1.19e-02
|
-1.74e-01
|
0.114000
|
DISEASES OF CARBOHYDRATE METABOLISM
|
29
|
1.07e-01
|
1.73e-01
|
0.384000
|
REGULATION OF TP53 ACTIVITY THROUGH ACETYLATION
|
30
|
1.01e-01
|
1.73e-01
|
0.375000
|
DNA METHYLATION
|
20
|
1.81e-01
|
1.73e-01
|
0.486000
|
CASPASE ACTIVATION VIA DEPENDENCE RECEPTORS IN THE ABSENCE OF LIGAND
|
10
|
3.45e-01
|
1.72e-01
|
0.677000
|
APOPTOTIC EXECUTION PHASE
|
45
|
4.58e-02
|
-1.72e-01
|
0.261000
|
MET ACTIVATES PTK2 SIGNALING
|
29
|
1.09e-01
|
1.72e-01
|
0.384000
|
SIGNAL REGULATORY PROTEIN FAMILY INTERACTIONS
|
11
|
3.24e-01
|
1.72e-01
|
0.664000
|
NEUREXINS AND NEUROLIGINS
|
54
|
2.92e-02
|
1.72e-01
|
0.193000
|
GABA RECEPTOR ACTIVATION
|
53
|
3.07e-02
|
-1.72e-01
|
0.200000
|
PHASE 4 RESTING MEMBRANE POTENTIAL
|
14
|
2.67e-01
|
1.71e-01
|
0.596000
|
DNA REPLICATION PRE INITIATION
|
81
|
7.72e-03
|
-1.71e-01
|
0.098500
|
CELL CYCLE CHECKPOINTS
|
243
|
4.44e-06
|
-1.71e-01
|
0.001730
|
PI 3K CASCADE FGFR2
|
16
|
2.37e-01
|
-1.71e-01
|
0.560000
|
SYNTHESIS OF PA
|
29
|
1.12e-01
|
1.71e-01
|
0.388000
|
DNA REPLICATION
|
123
|
1.16e-03
|
-1.70e-01
|
0.037000
|
GASTRIN CREB SIGNALLING PATHWAY VIA PKC AND MAPK
|
16
|
2.40e-01
|
-1.70e-01
|
0.561000
|
HIV TRANSCRIPTION INITIATION
|
45
|
4.97e-02
|
-1.69e-01
|
0.271000
|
EUKARYOTIC TRANSLATION INITIATION
|
114
|
1.84e-03
|
-1.69e-01
|
0.043300
|
DEATH RECEPTOR SIGNALLING
|
133
|
7.87e-04
|
1.69e-01
|
0.034100
|
SUMOYLATION OF DNA METHYLATION PROTEINS
|
16
|
2.44e-01
|
1.68e-01
|
0.565000
|
G PROTEIN ACTIVATION
|
22
|
1.73e-01
|
-1.68e-01
|
0.476000
|
REGULATED NECROSIS
|
46
|
4.94e-02
|
-1.68e-01
|
0.270000
|
NEPHRIN FAMILY INTERACTIONS
|
22
|
1.75e-01
|
1.67e-01
|
0.479000
|
BETA CATENIN PHOSPHORYLATION CASCADE
|
16
|
2.47e-01
|
-1.67e-01
|
0.568000
|
ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION
|
23
|
1.67e-01
|
1.67e-01
|
0.474000
|
DOWNSTREAM SIGNALING OF ACTIVATED FGFR1
|
24
|
1.60e-01
|
-1.66e-01
|
0.465000
|
SENSORY PROCESSING OF SOUND BY OUTER HAIR CELLS OF THE COCHLEA
|
41
|
6.66e-02
|
1.66e-01
|
0.305000
|
DEGRADATION OF GLI1 BY THE PROTEASOME
|
58
|
2.94e-02
|
-1.65e-01
|
0.193000
|
MATURATION OF SARS COV 2 SPIKE PROTEIN
|
29
|
1.23e-01
|
1.65e-01
|
0.413000
|
SIGNALING BY NOTCH3
|
48
|
4.79e-02
|
1.65e-01
|
0.265000
|
GAB1 SIGNALOSOME
|
13
|
3.03e-01
|
1.65e-01
|
0.645000
|
EFFECTS OF PIP2 HYDROLYSIS
|
27
|
1.38e-01
|
1.65e-01
|
0.437000
|
FORMATION OF THE CORNIFIED ENVELOPE
|
29
|
1.25e-01
|
1.65e-01
|
0.414000
|
KERATINIZATION
|
29
|
1.25e-01
|
1.65e-01
|
0.414000
|
G2 M CHECKPOINTS
|
135
|
9.61e-04
|
-1.65e-01
|
0.036900
|
G1 S DNA DAMAGE CHECKPOINTS
|
66
|
2.09e-02
|
-1.65e-01
|
0.157000
|
GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE
|
23
|
1.72e-01
|
1.64e-01
|
0.476000
|
P38MAPK EVENTS
|
12
|
3.31e-01
|
1.62e-01
|
0.668000
|
INTERLEUKIN 6 SIGNALING
|
10
|
3.75e-01
|
1.62e-01
|
0.695000
|
METABOLISM OF FOLATE AND PTERINES
|
15
|
2.78e-01
|
1.62e-01
|
0.611000
|
FORMATION OF INCISION COMPLEX IN GG NER
|
43
|
6.72e-02
|
-1.61e-01
|
0.305000
|
MTORC1 MEDIATED SIGNALLING
|
24
|
1.72e-01
|
-1.61e-01
|
0.476000
|
ATTENUATION PHASE
|
25
|
1.64e-01
|
1.61e-01
|
0.469000
|
DEGRADATION OF AXIN
|
54
|
4.15e-02
|
-1.60e-01
|
0.245000
|
COPI MEDIATED ANTEROGRADE TRANSPORT
|
90
|
8.67e-03
|
1.60e-01
|
0.103000
|
MITOCHONDRIAL CALCIUM ION TRANSPORT
|
23
|
1.84e-01
|
-1.60e-01
|
0.490000
|
FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC
|
19
|
2.27e-01
|
1.60e-01
|
0.545000
|
CS DS DEGRADATION
|
14
|
3.01e-01
|
1.60e-01
|
0.644000
|
FC EPSILON RECEPTOR FCERI SIGNALING
|
124
|
2.17e-03
|
-1.60e-01
|
0.047900
|
TRANSCRIPTIONAL REGULATION BY E2F6
|
34
|
1.08e-01
|
-1.59e-01
|
0.384000
|
MUCOPOLYSACCHARIDOSES
|
11
|
3.61e-01
|
1.59e-01
|
0.695000
|
TP53 REGULATES TRANSCRIPTION OF ADDITIONAL CELL CYCLE GENES WHOSE EXACT ROLE IN THE P53 PATHWAY REMAIN UNCERTAIN
|
20
|
2.19e-01
|
-1.59e-01
|
0.532000
|
FCERI MEDIATED NF KB ACTIVATION
|
77
|
1.60e-02
|
-1.59e-01
|
0.139000
|
CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS
|
12
|
3.42e-01
|
1.59e-01
|
0.675000
|
CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE
|
19
|
2.33e-01
|
-1.58e-01
|
0.555000
|
NR1H2 AND NR1H3 MEDIATED SIGNALING
|
38
|
9.20e-02
|
1.58e-01
|
0.356000
|
INTERFERON SIGNALING
|
161
|
5.55e-04
|
-1.58e-01
|
0.030900
|
KILLING MECHANISMS
|
10
|
3.89e-01
|
1.57e-01
|
0.708000
|
SIGNALING BY THE B CELL RECEPTOR BCR
|
104
|
5.72e-03
|
-1.57e-01
|
0.081600
|
TBC RABGAPS
|
43
|
7.54e-02
|
1.57e-01
|
0.316000
|
DEGRADATION OF DVL
|
56
|
4.29e-02
|
-1.56e-01
|
0.251000
|
HS GAG DEGRADATION
|
21
|
2.18e-01
|
1.55e-01
|
0.532000
|
AMINE LIGAND BINDING RECEPTORS
|
29
|
1.49e-01
|
1.55e-01
|
0.452000
|
DERMATAN SULFATE BIOSYNTHESIS
|
11
|
3.75e-01
|
1.55e-01
|
0.695000
|
GLUTATHIONE SYNTHESIS AND RECYCLING
|
11
|
3.76e-01
|
1.54e-01
|
0.695000
|
ER QUALITY CONTROL COMPARTMENT ERQC
|
21
|
2.21e-01
|
-1.54e-01
|
0.535000
|
INTERLEUKIN 6 FAMILY SIGNALING
|
20
|
2.33e-01
|
1.54e-01
|
0.555000
|
APC CDC20 MEDIATED DEGRADATION OF NEK2A
|
24
|
1.93e-01
|
-1.54e-01
|
0.502000
|
ANTIVIRAL MECHANISM BY IFN STIMULATED GENES
|
73
|
2.36e-02
|
-1.53e-01
|
0.170000
|
RESPONSE OF EIF2AK4 GCN2 TO AMINO ACID DEFICIENCY
|
94
|
1.07e-02
|
-1.53e-01
|
0.110000
|
TP53 REGULATES TRANSCRIPTION OF GENES INVOLVED IN G1 CELL CYCLE ARREST
|
13
|
3.41e-01
|
1.52e-01
|
0.675000
|
PLATELET ADHESION TO EXPOSED COLLAGEN
|
11
|
3.81e-01
|
-1.52e-01
|
0.699000
|
MOLECULES ASSOCIATED WITH ELASTIC FIBRES
|
31
|
1.43e-01
|
1.52e-01
|
0.441000
|
MITOTIC G1 PHASE AND G1 S TRANSITION
|
142
|
1.81e-03
|
-1.52e-01
|
0.043300
|
SHC MEDIATED CASCADE FGFR1
|
14
|
3.28e-01
|
-1.51e-01
|
0.667000
|
FRS MEDIATED FGFR2 SIGNALING
|
18
|
2.68e-01
|
-1.51e-01
|
0.596000
|
WNT5A DEPENDENT INTERNALIZATION OF FZD2 FZD5 AND ROR2
|
13
|
3.47e-01
|
1.51e-01
|
0.678000
|
REGULATION OF PTEN STABILITY AND ACTIVITY
|
67
|
3.31e-02
|
-1.51e-01
|
0.211000
|
CYCLIN A CDK2 ASSOCIATED EVENTS AT S PHASE ENTRY
|
84
|
1.71e-02
|
-1.51e-01
|
0.143000
|
PRESYNAPTIC FUNCTION OF KAINATE RECEPTORS
|
19
|
2.57e-01
|
-1.50e-01
|
0.580000
|
AUF1 HNRNP D0 BINDS AND DESTABILIZES MRNA
|
54
|
5.62e-02
|
-1.50e-01
|
0.284000
|
HEDGEHOG LIGAND BIOGENESIS
|
62
|
4.08e-02
|
-1.50e-01
|
0.243000
|
COMPLEX I BIOGENESIS
|
56
|
5.26e-02
|
-1.50e-01
|
0.278000
|
NON INTEGRIN MEMBRANE ECM INTERACTIONS
|
56
|
5.28e-02
|
1.50e-01
|
0.278000
|
LYSOSPHINGOLIPID AND LPA RECEPTORS
|
11
|
3.90e-01
|
-1.50e-01
|
0.708000
|
BUTYRATE RESPONSE FACTOR 1 BRF1 BINDS AND DESTABILIZES MRNA
|
16
|
3.01e-01
|
-1.50e-01
|
0.644000
|
CONSTITUTIVE SIGNALING BY EGFRVIII
|
15
|
3.16e-01
|
-1.49e-01
|
0.655000
|
COPI DEPENDENT GOLGI TO ER RETROGRADE TRAFFIC
|
86
|
1.69e-02
|
1.49e-01
|
0.143000
|
ACTIVATION OF KAINATE RECEPTORS UPON GLUTAMATE BINDING
|
28
|
1.72e-01
|
-1.49e-01
|
0.476000
|
GLYCEROPHOSPHOLIPID BIOSYNTHESIS
|
107
|
8.05e-03
|
1.48e-01
|
0.101000
|
PLASMA LIPOPROTEIN CLEARANCE
|
26
|
1.92e-01
|
1.48e-01
|
0.502000
|
TNFR1 INDUCED NFKAPPAB SIGNALING PATHWAY
|
29
|
1.69e-01
|
1.48e-01
|
0.475000
|
GRB2 EVENTS IN ERBB2 SIGNALING
|
14
|
3.40e-01
|
-1.47e-01
|
0.675000
|
REGULATION OF EXPRESSION OF SLITS AND ROBOS
|
161
|
1.27e-03
|
-1.47e-01
|
0.038000
|
NEGATIVE REGULATION OF FLT3
|
15
|
3.26e-01
|
1.46e-01
|
0.667000
|
REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS
|
85
|
2.07e-02
|
-1.45e-01
|
0.157000
|
PROTEIN PROTEIN INTERACTIONS AT SYNAPSES
|
85
|
2.07e-02
|
1.45e-01
|
0.157000
|
REDUCTION OF CYTOSOLIC CA LEVELS
|
12
|
3.85e-01
|
-1.45e-01
|
0.703000
|
RORA ACTIVATES GENE EXPRESSION
|
18
|
2.87e-01
|
1.45e-01
|
0.626000
|
FORMATION OF APOPTOSOME
|
10
|
4.28e-01
|
-1.45e-01
|
0.738000
|
ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON
|
17
|
3.03e-01
|
1.44e-01
|
0.645000
|
PCNA DEPENDENT LONG PATCH BASE EXCISION REPAIR
|
21
|
2.53e-01
|
-1.44e-01
|
0.578000
|
METABOLISM OF FAT SOLUBLE VITAMINS
|
32
|
1.59e-01
|
1.44e-01
|
0.465000
|
SEPARATION OF SISTER CHROMATIDS
|
165
|
1.57e-03
|
-1.43e-01
|
0.041700
|
RUNX1 INTERACTS WITH CO FACTORS WHOSE PRECISE EFFECT ON RUNX1 TARGETS IS NOT KNOWN
|
37
|
1.33e-01
|
1.43e-01
|
0.429000
|
CALNEXIN CALRETICULIN CYCLE
|
26
|
2.09e-01
|
-1.42e-01
|
0.522000
|
REGULATION OF RUNX3 EXPRESSION AND ACTIVITY
|
53
|
7.29e-02
|
-1.42e-01
|
0.311000
|
TERMINATION OF TRANSLESION DNA SYNTHESIS
|
31
|
1.70e-01
|
-1.42e-01
|
0.475000
|
HEME BIOSYNTHESIS
|
13
|
3.74e-01
|
1.42e-01
|
0.695000
|
BLOOD GROUP SYSTEMS BIOSYNTHESIS
|
12
|
3.94e-01
|
-1.42e-01
|
0.708000
|
HDR THROUGH SINGLE STRAND ANNEALING SSA
|
36
|
1.40e-01
|
-1.42e-01
|
0.439000
|
SHC1 EVENTS IN ERBB4 SIGNALING
|
12
|
3.95e-01
|
-1.42e-01
|
0.710000
|
CD28 CO STIMULATION
|
30
|
1.80e-01
|
-1.42e-01
|
0.484000
|
LONG TERM POTENTIATION
|
23
|
2.41e-01
|
1.41e-01
|
0.562000
|
PI 3K CASCADE FGFR1
|
14
|
3.60e-01
|
-1.41e-01
|
0.695000
|
CELLULAR RESPONSE TO HYPOXIA
|
72
|
3.85e-02
|
-1.41e-01
|
0.234000
|
REGULATION OF RAS BY GAPS
|
67
|
4.63e-02
|
-1.41e-01
|
0.262000
|
TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES
|
85
|
2.50e-02
|
1.41e-01
|
0.175000
|
RAC1 GTPASE CYCLE
|
176
|
1.39e-03
|
1.40e-01
|
0.038200
|
PYRIMIDINE SALVAGE
|
10
|
4.44e-01
|
1.40e-01
|
0.750000
|
ROLE OF LAT2 NTAL LAB ON CALCIUM MOBILIZATION
|
14
|
3.69e-01
|
-1.39e-01
|
0.695000
|
MICRORNA MIRNA BIOGENESIS
|
24
|
2.40e-01
|
1.39e-01
|
0.561000
|
SIGNALING BY NOTCH1
|
75
|
3.83e-02
|
1.38e-01
|
0.233000
|
RIPK1 MEDIATED REGULATED NECROSIS
|
25
|
2.32e-01
|
-1.38e-01
|
0.553000
|
FGFR2 LIGAND BINDING AND ACTIVATION
|
11
|
4.29e-01
|
-1.38e-01
|
0.738000
|
SIGNALING BY CYTOSOLIC FGFR1 FUSION MUTANTS
|
18
|
3.11e-01
|
-1.38e-01
|
0.652000
|
SENSORY PROCESSING OF SOUND
|
61
|
6.28e-02
|
1.38e-01
|
0.296000
|
TRANSLESION SYNTHESIS BY Y FAMILY DNA POLYMERASES BYPASSES LESIONS ON DNA TEMPLATE
|
38
|
1.42e-01
|
-1.38e-01
|
0.441000
|
G BETA GAMMA SIGNALLING THROUGH PI3KGAMMA
|
23
|
2.55e-01
|
-1.37e-01
|
0.580000
|
MITOTIC METAPHASE AND ANAPHASE
|
206
|
7.01e-04
|
-1.37e-01
|
0.031600
|
SODIUM CALCIUM EXCHANGERS
|
10
|
4.53e-01
|
-1.37e-01
|
0.758000
|
INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1
|
13
|
3.92e-01
|
-1.37e-01
|
0.708000
|
HIV ELONGATION ARREST AND RECOVERY
|
32
|
1.81e-01
|
1.37e-01
|
0.486000
|
SEMAPHORIN INTERACTIONS
|
64
|
5.93e-02
|
1.36e-01
|
0.288000
|
PHOSPHOLIPID METABOLISM
|
185
|
1.40e-03
|
1.36e-01
|
0.038200
|
SELENOAMINO ACID METABOLISM
|
109
|
1.41e-02
|
-1.36e-01
|
0.128000
|
FANCONI ANEMIA PATHWAY
|
36
|
1.58e-01
|
1.36e-01
|
0.465000
|
ONCOGENE INDUCED SENESCENCE
|
32
|
1.84e-01
|
1.36e-01
|
0.489000
|
TCR SIGNALING
|
102
|
1.83e-02
|
-1.35e-01
|
0.144000
|
VOLTAGE GATED POTASSIUM CHANNELS
|
40
|
1.39e-01
|
1.35e-01
|
0.437000
|
ADHERENS JUNCTIONS INTERACTIONS
|
29
|
2.08e-01
|
-1.35e-01
|
0.522000
|
NONSENSE MEDIATED DECAY NMD
|
109
|
1.53e-02
|
-1.35e-01
|
0.135000
|
PROLONGED ERK ACTIVATION EVENTS
|
13
|
4.02e-01
|
-1.34e-01
|
0.717000
|
CHROMATIN MODIFYING ENZYMES
|
218
|
6.79e-04
|
1.34e-01
|
0.031600
|
INLB MEDIATED ENTRY OF LISTERIA MONOCYTOGENES INTO HOST CELL
|
15
|
3.70e-01
|
-1.34e-01
|
0.695000
|
G PROTEIN BETA GAMMA SIGNALLING
|
30
|
2.05e-01
|
-1.34e-01
|
0.518000
|
MEIOTIC RECOMBINATION
|
38
|
1.54e-01
|
-1.34e-01
|
0.460000
|
CLEC7A DECTIN 1 SIGNALING
|
95
|
2.45e-02
|
-1.34e-01
|
0.175000
|
C TYPE LECTIN RECEPTORS CLRS
|
114
|
1.41e-02
|
-1.33e-01
|
0.128000
|
GOLGI ASSOCIATED VESICLE BIOGENESIS
|
54
|
9.31e-02
|
-1.32e-01
|
0.356000
|
AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL
|
14
|
3.93e-01
|
1.32e-01
|
0.708000
|
PROCESSING OF INTRONLESS PRE MRNAS
|
19
|
3.21e-01
|
-1.32e-01
|
0.659000
|
DAP12 INTERACTIONS
|
29
|
2.20e-01
|
-1.32e-01
|
0.534000
|
DECTIN 1 MEDIATED NONCANONICAL NF KB SIGNALING
|
60
|
7.84e-02
|
-1.31e-01
|
0.327000
|
GLYCOSAMINOGLYCAN METABOLISM
|
114
|
1.55e-02
|
1.31e-01
|
0.136000
|
RHOC GTPASE CYCLE
|
73
|
5.25e-02
|
1.31e-01
|
0.278000
|
N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE
|
35
|
1.80e-01
|
-1.31e-01
|
0.484000
|
SHC MEDIATED CASCADE FGFR3
|
13
|
4.14e-01
|
-1.31e-01
|
0.726000
|
CA2 PATHWAY
|
56
|
9.04e-02
|
-1.31e-01
|
0.354000
|
DOPAMINE NEUROTRANSMITTER RELEASE CYCLE
|
23
|
2.78e-01
|
1.31e-01
|
0.611000
|
PROCESSING OF DNA DOUBLE STRAND BREAK ENDS
|
71
|
5.69e-02
|
-1.31e-01
|
0.287000
|
EXTRA NUCLEAR ESTROGEN SIGNALING
|
65
|
6.87e-02
|
-1.31e-01
|
0.307000
|
HOST INTERACTIONS OF HIV FACTORS
|
124
|
1.21e-02
|
-1.31e-01
|
0.115000
|
RAS ACTIVATION UPON CA2 INFLUX THROUGH NMDA RECEPTOR
|
20
|
3.12e-01
|
1.31e-01
|
0.653000
|
EUKARYOTIC TRANSLATION ELONGATION
|
87
|
3.69e-02
|
-1.29e-01
|
0.226000
|
FOXO MEDIATED TRANSCRIPTION OF OXIDATIVE STRESS METABOLIC AND NEURONAL GENES
|
23
|
2.83e-01
|
-1.29e-01
|
0.618000
|
DSCAM INTERACTIONS
|
10
|
4.83e-01
|
1.28e-01
|
0.782000
|
HCMV EARLY EVENTS
|
80
|
4.76e-02
|
1.28e-01
|
0.265000
|
SPRY REGULATION OF FGF SIGNALING
|
16
|
3.75e-01
|
1.28e-01
|
0.695000
|
JOSEPHIN DOMAIN DUBS
|
11
|
4.63e-01
|
1.28e-01
|
0.767000
|
STIMULI SENSING CHANNELS
|
74
|
5.75e-02
|
1.28e-01
|
0.287000
|
L1CAM INTERACTIONS
|
107
|
2.26e-02
|
1.28e-01
|
0.165000
|
RHOA GTPASE CYCLE
|
141
|
9.10e-03
|
1.27e-01
|
0.105000
|
ASSEMBLY OF THE HIV VIRION
|
16
|
3.79e-01
|
1.27e-01
|
0.697000
|
COSTIMULATION BY THE CD28 FAMILY
|
49
|
1.24e-01
|
-1.27e-01
|
0.414000
|
SIGNALING BY MODERATE KINASE ACTIVITY BRAF MUTANTS
|
41
|
1.61e-01
|
1.27e-01
|
0.466000
|
INFLUENZA INFECTION
|
145
|
8.79e-03
|
-1.26e-01
|
0.103000
|
PLASMA LIPOPROTEIN REMODELING
|
15
|
3.99e-01
|
1.26e-01
|
0.712000
|
ER TO GOLGI ANTEROGRADE TRANSPORT
|
139
|
1.05e-02
|
1.26e-01
|
0.110000
|
METABOLISM OF PORPHYRINS
|
19
|
3.43e-01
|
1.26e-01
|
0.676000
|
NOTCH3 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION
|
23
|
2.98e-01
|
1.25e-01
|
0.639000
|
ACETYLCHOLINE REGULATES INSULIN SECRETION
|
10
|
4.93e-01
|
1.25e-01
|
0.782000
|
STING MEDIATED INDUCTION OF HOST IMMUNE RESPONSES
|
14
|
4.19e-01
|
1.25e-01
|
0.728000
|
G ALPHA S SIGNALLING EVENTS
|
98
|
3.49e-02
|
1.23e-01
|
0.218000
|
METABOLISM OF COFACTORS
|
18
|
3.66e-01
|
-1.23e-01
|
0.695000
|
IKK COMPLEX RECRUITMENT MEDIATED BY RIP1
|
22
|
3.18e-01
|
-1.23e-01
|
0.657000
|
ACYL CHAIN REMODELLING OF PS
|
14
|
4.27e-01
|
1.23e-01
|
0.738000
|
EPH EPHRIN MEDIATED REPULSION OF CELLS
|
51
|
1.30e-01
|
1.23e-01
|
0.422000
|
CYCLIN A B1 B2 ASSOCIATED EVENTS DURING G2 M TRANSITION
|
22
|
3.20e-01
|
-1.23e-01
|
0.659000
|
FRS MEDIATED FGFR1 SIGNALING
|
16
|
3.97e-01
|
-1.22e-01
|
0.710000
|
TRANSCRIPTION OF E2F TARGETS UNDER NEGATIVE CONTROL BY DREAM COMPLEX
|
18
|
3.70e-01
|
-1.22e-01
|
0.695000
|
INTERLEUKIN 4 AND INTERLEUKIN 13 SIGNALING
|
80
|
5.92e-02
|
-1.22e-01
|
0.288000
|
APC C CDC20 MEDIATED DEGRADATION OF CYCLIN B
|
21
|
3.33e-01
|
-1.22e-01
|
0.668000
|
SIGNALING BY NOTCH1 PEST DOMAIN MUTANTS IN CANCER
|
59
|
1.06e-01
|
1.22e-01
|
0.383000
|
METABOLISM OF ANGIOTENSINOGEN TO ANGIOTENSINS
|
10
|
5.05e-01
|
-1.22e-01
|
0.786000
|
NF KB ACTIVATION THROUGH FADD RIP 1 PATHWAY MEDIATED BY CASPASE 8 AND 10
|
11
|
4.86e-01
|
-1.21e-01
|
0.782000
|
TRAFFICKING OF AMPA RECEPTORS
|
31
|
2.43e-01
|
1.21e-01
|
0.564000
|
N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI
|
24
|
3.05e-01
|
1.21e-01
|
0.646000
|
SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE
|
15
|
4.18e-01
|
1.21e-01
|
0.728000
|
TRANSCRIPTIONAL REGULATION OF GRANULOPOIESIS
|
44
|
1.66e-01
|
1.21e-01
|
0.472000
|
CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS
|
11
|
4.89e-01
|
1.21e-01
|
0.782000
|
DOWNSTREAM SIGNALING OF ACTIVATED FGFR4
|
18
|
3.76e-01
|
-1.21e-01
|
0.695000
|
MISMATCH REPAIR
|
14
|
4.35e-01
|
-1.20e-01
|
0.744000
|
PI 3K CASCADE FGFR3
|
13
|
4.52e-01
|
-1.20e-01
|
0.758000
|
GLUCOSE METABOLISM
|
80
|
6.28e-02
|
1.20e-01
|
0.296000
|
ERCC6 CSB AND EHMT2 G9A POSITIVELY REGULATE RRNA EXPRESSION
|
32
|
2.39e-01
|
1.20e-01
|
0.561000
|
TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION
|
77
|
6.85e-02
|
1.20e-01
|
0.307000
|
TP53 REGULATES TRANSCRIPTION OF SEVERAL ADDITIONAL CELL DEATH GENES WHOSE SPECIFIC ROLES IN P53 DEPENDENT APOPTOSIS REMAIN UNCERTAIN
|
12
|
4.72e-01
|
1.20e-01
|
0.774000
|
ENOS ACTIVATION
|
11
|
4.91e-01
|
-1.20e-01
|
0.782000
|
IRON UPTAKE AND TRANSPORT
|
51
|
1.41e-01
|
-1.19e-01
|
0.441000
|
P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS
|
12
|
4.76e-01
|
1.19e-01
|
0.778000
|
PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE
|
51
|
1.42e-01
|
-1.19e-01
|
0.441000
|
TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS
|
17
|
3.97e-01
|
1.19e-01
|
0.710000
|
OXIDATIVE STRESS INDUCED SENESCENCE
|
78
|
7.00e-02
|
1.19e-01
|
0.308000
|
LISTERIA MONOCYTOGENES ENTRY INTO HOST CELLS
|
19
|
3.71e-01
|
-1.19e-01
|
0.695000
|
CRISTAE FORMATION
|
31
|
2.56e-01
|
-1.18e-01
|
0.580000
|
MITOCHONDRIAL IRON SULFUR CLUSTER BIOGENESIS
|
13
|
4.62e-01
|
1.18e-01
|
0.767000
|
TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION
|
16
|
4.15e-01
|
1.18e-01
|
0.728000
|
SYNTHESIS OF IP2 IP AND INS IN THE CYTOSOL
|
13
|
4.65e-01
|
1.17e-01
|
0.769000
|
UPTAKE AND FUNCTION OF ANTHRAX TOXINS
|
11
|
5.02e-01
|
1.17e-01
|
0.786000
|
OTHER SEMAPHORIN INTERACTIONS
|
19
|
3.81e-01
|
1.16e-01
|
0.699000
|
MEIOSIS
|
64
|
1.09e-01
|
-1.16e-01
|
0.384000
|
CASPASE ACTIVATION VIA DEATH RECEPTORS IN THE PRESENCE OF LIGAND
|
14
|
4.53e-01
|
-1.16e-01
|
0.758000
|
SIGNALING BY ERBB2 IN CANCER
|
24
|
3.27e-01
|
-1.16e-01
|
0.667000
|
TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION
|
168
|
9.80e-03
|
1.16e-01
|
0.109000
|
ASSEMBLY OF ACTIVE LPL AND LIPC LIPASE COMPLEXES
|
10
|
5.27e-01
|
1.16e-01
|
0.805000
|
REGULATION OF TNFR1 SIGNALING
|
34
|
2.44e-01
|
1.16e-01
|
0.565000
|
PEROXISOMAL LIPID METABOLISM
|
26
|
3.10e-01
|
-1.15e-01
|
0.649000
|
HIV INFECTION
|
220
|
3.36e-03
|
-1.15e-01
|
0.060600
|
NETRIN 1 SIGNALING
|
48
|
1.70e-01
|
1.15e-01
|
0.475000
|
HDMS DEMETHYLATE HISTONES
|
27
|
3.04e-01
|
1.14e-01
|
0.645000
|
SIGNALING BY ERBB4
|
56
|
1.39e-01
|
-1.14e-01
|
0.437000
|
FCERI MEDIATED MAPK ACTIVATION
|
28
|
2.95e-01
|
-1.14e-01
|
0.638000
|
SUMOYLATION OF DNA DAMAGE RESPONSE AND REPAIR PROTEINS
|
73
|
9.24e-02
|
-1.14e-01
|
0.356000
|
IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL
|
45
|
1.87e-01
|
-1.14e-01
|
0.494000
|
POSTMITOTIC NUCLEAR PORE COMPLEX NPC REFORMATION
|
26
|
3.16e-01
|
-1.14e-01
|
0.655000
|
CARGO TRAFFICKING TO THE PERICILIARY MEMBRANE
|
49
|
1.69e-01
|
-1.14e-01
|
0.475000
|
DISEASES OF DNA REPAIR
|
11
|
5.16e-01
|
-1.13e-01
|
0.795000
|
DEADENYLATION DEPENDENT MRNA DECAY
|
55
|
1.49e-01
|
-1.12e-01
|
0.452000
|
O LINKED GLYCOSYLATION OF MUCINS
|
42
|
2.08e-01
|
1.12e-01
|
0.522000
|
INFLAMMASOMES
|
19
|
3.97e-01
|
-1.12e-01
|
0.710000
|
SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL
|
13
|
4.83e-01
|
1.12e-01
|
0.782000
|
TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX WITHIN TLR4 COMPLEX
|
16
|
4.39e-01
|
1.12e-01
|
0.744000
|
RESPIRATORY ELECTRON TRANSPORT
|
102
|
5.13e-02
|
-1.12e-01
|
0.277000
|
SULFUR AMINO ACID METABOLISM
|
22
|
3.65e-01
|
1.12e-01
|
0.695000
|
SLC MEDIATED TRANSMEMBRANE TRANSPORT
|
186
|
8.73e-03
|
1.12e-01
|
0.103000
|
SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE
|
11
|
5.22e-01
|
-1.12e-01
|
0.801000
|
HEPARAN SULFATE HEPARIN HS GAG METABOLISM
|
52
|
1.64e-01
|
1.11e-01
|
0.470000
|
METABOLISM OF CARBOHYDRATES
|
257
|
2.16e-03
|
1.11e-01
|
0.047900
|
SIGNALING BY ROBO RECEPTORS
|
206
|
6.05e-03
|
-1.11e-01
|
0.085300
|
RESOLUTION OF SISTER CHROMATID COHESION
|
101
|
5.40e-02
|
-1.11e-01
|
0.278000
|
SHC1 EVENTS IN EGFR SIGNALING
|
10
|
5.48e-01
|
-1.10e-01
|
0.812000
|
HATS ACETYLATE HISTONES
|
92
|
6.92e-02
|
1.10e-01
|
0.307000
|
ABC TRANSPORTER DISORDERS
|
69
|
1.15e-01
|
-1.10e-01
|
0.398000
|
PROGRAMMED CELL DEATH
|
188
|
9.88e-03
|
-1.09e-01
|
0.109000
|
MAP2K AND MAPK ACTIVATION
|
36
|
2.58e-01
|
1.09e-01
|
0.581000
|
DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE
|
37
|
2.56e-01
|
-1.08e-01
|
0.580000
|
PENTOSE PHOSPHATE PATHWAY
|
13
|
5.02e-01
|
-1.07e-01
|
0.786000
|
ERKS ARE INACTIVATED
|
13
|
5.03e-01
|
1.07e-01
|
0.786000
|
DOWNSTREAM SIGNALING OF ACTIVATED FGFR2
|
23
|
3.74e-01
|
-1.07e-01
|
0.695000
|
PI METABOLISM
|
79
|
1.01e-01
|
1.07e-01
|
0.375000
|
BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN GENE EXPRESSION
|
26
|
3.47e-01
|
1.07e-01
|
0.678000
|
IL 6 TYPE CYTOKINE RECEPTOR LIGAND INTERACTIONS
|
14
|
4.92e-01
|
1.06e-01
|
0.782000
|
PROCESSIVE SYNTHESIS ON THE C STRAND OF THE TELOMERE
|
19
|
4.23e-01
|
-1.06e-01
|
0.734000
|
THE CITRIC ACID TCA CYCLE AND RESPIRATORY ELECTRON TRANSPORT
|
172
|
1.67e-02
|
-1.06e-01
|
0.143000
|
INTEGRATION OF ENERGY METABOLISM
|
97
|
7.23e-02
|
1.06e-01
|
0.311000
|
UNFOLDED PROTEIN RESPONSE UPR
|
85
|
9.29e-02
|
1.05e-01
|
0.356000
|
RHO GTPASES ACTIVATE NADPH OXIDASES
|
18
|
4.43e-01
|
1.05e-01
|
0.750000
|
DEGRADATION OF BETA CATENIN BY THE DESTRUCTION COMPLEX
|
83
|
1.01e-01
|
-1.04e-01
|
0.375000
|
SYNTHESIS OF PROSTAGLANDINS PG AND THROMBOXANES TX
|
13
|
5.15e-01
|
-1.04e-01
|
0.795000
|
PERK REGULATES GENE EXPRESSION
|
28
|
3.40e-01
|
-1.04e-01
|
0.675000
|
PKMTS METHYLATE HISTONE LYSINES
|
48
|
2.13e-01
|
1.04e-01
|
0.525000
|
FREE FATTY ACIDS REGULATE INSULIN SECRETION
|
10
|
5.70e-01
|
-1.04e-01
|
0.829000
|
PHASE II CONJUGATION OF COMPOUNDS
|
61
|
1.62e-01
|
-1.04e-01
|
0.467000
|
DDX58 IFIH1 MEDIATED INDUCTION OF INTERFERON ALPHA BETA
|
62
|
1.59e-01
|
-1.04e-01
|
0.465000
|
G0 AND EARLY G1
|
25
|
3.71e-01
|
-1.03e-01
|
0.695000
|
FRS MEDIATED FGFR3 SIGNALING
|
15
|
4.89e-01
|
-1.03e-01
|
0.782000
|
GLYCOGEN STORAGE DISEASES
|
12
|
5.36e-01
|
1.03e-01
|
0.811000
|
ACTIVATION OF MATRIX METALLOPROTEINASES
|
15
|
4.90e-01
|
1.03e-01
|
0.782000
|
REGULATED PROTEOLYSIS OF P75NTR
|
12
|
5.37e-01
|
1.03e-01
|
0.811000
|
ACTIVATION OF ANTERIOR HOX GENES IN HINDBRAIN DEVELOPMENT DURING EARLY EMBRYOGENESIS
|
66
|
1.50e-01
|
1.02e-01
|
0.453000
|
METALLOPROTEASE DUBS
|
26
|
3.66e-01
|
-1.02e-01
|
0.695000
|
HCMV INFECTION
|
103
|
7.31e-02
|
1.02e-01
|
0.311000
|
APOPTOSIS
|
166
|
2.33e-02
|
-1.02e-01
|
0.169000
|
IONOTROPIC ACTIVITY OF KAINATE RECEPTORS
|
10
|
5.77e-01
|
-1.02e-01
|
0.832000
|
FCERI MEDIATED CA 2 MOBILIZATION
|
26
|
3.69e-01
|
-1.02e-01
|
0.695000
|
TRANSLATION
|
286
|
3.25e-03
|
-1.01e-01
|
0.059500
|
TRANSCRIPTIONAL REGULATION BY RUNX2
|
111
|
6.58e-02
|
-1.01e-01
|
0.304000
|
REPRODUCTION
|
76
|
1.28e-01
|
-1.01e-01
|
0.418000
|
DETOXIFICATION OF REACTIVE OXYGEN SPECIES
|
31
|
3.32e-01
|
-1.01e-01
|
0.668000
|
EPHRIN SIGNALING
|
19
|
4.48e-01
|
1.01e-01
|
0.754000
|
CARDIAC CONDUCTION
|
108
|
7.21e-02
|
1.00e-01
|
0.311000
|
RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS
|
125
|
5.46e-02
|
-9.96e-02
|
0.279000
|
RND3 GTPASE CYCLE
|
38
|
2.88e-01
|
9.96e-02
|
0.627000
|
TNFS BIND THEIR PHYSIOLOGICAL RECEPTORS
|
15
|
5.05e-01
|
9.94e-02
|
0.786000
|
LYSINE CATABOLISM
|
10
|
5.87e-01
|
9.92e-02
|
0.835000
|
NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION
|
48
|
2.35e-01
|
9.91e-02
|
0.557000
|
NEGATIVE REGULATION OF MAPK PATHWAY
|
42
|
2.68e-01
|
9.88e-02
|
0.596000
|
SIGNALING BY FGFR2 IN DISEASE
|
36
|
3.05e-01
|
-9.88e-02
|
0.646000
|
INACTIVATION OF CSF3 G CSF SIGNALING
|
24
|
4.03e-01
|
-9.87e-02
|
0.717000
|
TNF SIGNALING
|
43
|
2.64e-01
|
9.84e-02
|
0.592000
|
ABC TRANSPORTERS IN LIPID HOMEOSTASIS
|
13
|
5.40e-01
|
9.82e-02
|
0.811000
|
LAGGING STRAND SYNTHESIS
|
20
|
4.47e-01
|
-9.81e-02
|
0.754000
|
RND2 GTPASE CYCLE
|
38
|
2.97e-01
|
9.78e-02
|
0.639000
|
MRNA SPLICING
|
188
|
2.10e-02
|
-9.78e-02
|
0.157000
|
SYNTHESIS OF PYROPHOSPHATES IN THE CYTOSOL
|
10
|
5.94e-01
|
9.74e-02
|
0.838000
|
RHOH GTPASE CYCLE
|
37
|
3.06e-01
|
-9.72e-02
|
0.647000
|
PLASMA LIPOPROTEIN ASSEMBLY
|
11
|
5.77e-01
|
-9.72e-02
|
0.832000
|
REGULATION OF MECP2 EXPRESSION AND ACTIVITY
|
30
|
3.57e-01
|
9.72e-02
|
0.694000
|
RRNA PROCESSING
|
194
|
2.00e-02
|
-9.70e-02
|
0.156000
|
COPI INDEPENDENT GOLGI TO ER RETROGRADE TRAFFIC
|
44
|
2.70e-01
|
9.62e-02
|
0.599000
|
DISEASES OF MITOTIC CELL CYCLE
|
37
|
3.14e-01
|
-9.58e-02
|
0.654000
|
TRANS GOLGI NETWORK VESICLE BUDDING
|
69
|
1.69e-01
|
-9.57e-02
|
0.475000
|
CELLULAR RESPONSE TO STARVATION
|
145
|
4.71e-02
|
-9.56e-02
|
0.265000
|
ACTIVATION OF NMDA RECEPTORS AND POSTSYNAPTIC EVENTS
|
83
|
1.32e-01
|
9.56e-02
|
0.428000
|
PROCESSING OF CAPPED INTRON CONTAINING PRE MRNA
|
237
|
1.15e-02
|
-9.55e-02
|
0.113000
|
THROMBOXANE SIGNALLING THROUGH TP RECEPTOR
|
22
|
4.38e-01
|
-9.54e-02
|
0.744000
|
SIGNAL AMPLIFICATION
|
30
|
3.66e-01
|
-9.53e-02
|
0.695000
|
TRANSCRIPTION OF THE HIV GENOME
|
67
|
1.78e-01
|
-9.53e-02
|
0.482000
|
SIGNALING BY CSF3 G CSF
|
29
|
3.75e-01
|
-9.52e-02
|
0.695000
|
CLASS I MHC MEDIATED ANTIGEN PROCESSING PRESENTATION
|
344
|
2.54e-03
|
-9.49e-02
|
0.052100
|
DEACTIVATION OF THE BETA CATENIN TRANSACTIVATING COMPLEX
|
41
|
2.94e-01
|
9.48e-02
|
0.635000
|
TP53 REGULATES TRANSCRIPTION OF CASPASE ACTIVATORS AND CASPASES
|
11
|
5.86e-01
|
-9.48e-02
|
0.835000
|
TAK1 ACTIVATES NFKB BY PHOSPHORYLATION AND ACTIVATION OF IKKS COMPLEX
|
30
|
3.69e-01
|
9.47e-02
|
0.695000
|
DEREGULATED CDK5 TRIGGERS MULTIPLE NEURODEGENERATIVE PATHWAYS IN ALZHEIMER S DISEASE MODELS
|
19
|
4.76e-01
|
9.45e-02
|
0.778000
|
SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE
|
16
|
5.13e-01
|
-9.44e-02
|
0.795000
|
HDR THROUGH HOMOLOGOUS RECOMBINATION HRR
|
63
|
1.95e-01
|
-9.44e-02
|
0.506000
|
ZINC TRANSPORTERS
|
16
|
5.18e-01
|
-9.35e-02
|
0.797000
|
SIGNALING BY PDGF
|
57
|
2.23e-01
|
9.34e-02
|
0.536000
|
MAPK6 MAPK4 SIGNALING
|
84
|
1.39e-01
|
-9.34e-02
|
0.437000
|
INTRA GOLGI TRAFFIC
|
43
|
2.89e-01
|
9.34e-02
|
0.627000
|
PREGNENOLONE BIOSYNTHESIS
|
12
|
5.77e-01
|
9.31e-02
|
0.832000
|
DEPOLYMERISATION OF THE NUCLEAR LAMINA
|
13
|
5.62e-01
|
9.28e-02
|
0.827000
|
ABC FAMILY PROTEINS MEDIATED TRANSPORT
|
93
|
1.23e-01
|
-9.25e-02
|
0.413000
|
FORMATION OF ATP BY CHEMIOSMOTIC COUPLING
|
18
|
4.97e-01
|
-9.24e-02
|
0.784000
|
RUNX2 REGULATES BONE DEVELOPMENT
|
29
|
3.90e-01
|
9.22e-02
|
0.708000
|
PLASMA LIPOPROTEIN ASSEMBLY REMODELING AND CLEARANCE
|
49
|
2.65e-01
|
9.21e-02
|
0.592000
|
FCGAMMA RECEPTOR FCGR DEPENDENT PHAGOCYTOSIS
|
81
|
1.53e-01
|
9.20e-02
|
0.459000
|
ION CHANNEL TRANSPORT
|
139
|
6.30e-02
|
9.14e-02
|
0.296000
|
SENESCENCE ASSOCIATED SECRETORY PHENOTYPE SASP
|
63
|
2.10e-01
|
9.13e-02
|
0.523000
|
GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION
|
19
|
4.92e-01
|
-9.11e-02
|
0.782000
|
NS1 MEDIATED EFFECTS ON HOST PATHWAYS
|
37
|
3.39e-01
|
-9.09e-02
|
0.675000
|
SELECTIVE AUTOPHAGY
|
71
|
1.87e-01
|
9.06e-02
|
0.494000
|
DNA DAMAGE RECOGNITION IN GG NER
|
38
|
3.35e-01
|
9.05e-02
|
0.669000
|
METAL ION SLC TRANSPORTERS
|
25
|
4.34e-01
|
-9.04e-02
|
0.744000
|
M PHASE
|
339
|
4.39e-03
|
-9.02e-02
|
0.068600
|
DISASSEMBLY OF THE DESTRUCTION COMPLEX AND RECRUITMENT OF AXIN TO THE MEMBRANE
|
27
|
4.18e-01
|
9.01e-02
|
0.728000
|
CYCLIN D ASSOCIATED EVENTS IN G1
|
45
|
2.96e-01
|
-9.00e-02
|
0.639000
|
METABOLISM OF WATER SOLUBLE VITAMINS AND COFACTORS
|
101
|
1.19e-01
|
8.99e-02
|
0.409000
|
METABOLISM OF RNA
|
644
|
1.08e-04
|
-8.98e-02
|
0.010600
|
SIGNALING BY PTK6
|
50
|
2.72e-01
|
8.98e-02
|
0.602000
|
PINK1 PRKN MEDIATED MITOPHAGY
|
22
|
4.66e-01
|
-8.97e-02
|
0.770000
|
TELOMERE C STRAND LAGGING STRAND SYNTHESIS
|
33
|
3.75e-01
|
-8.93e-02
|
0.695000
|
ION HOMEOSTASIS
|
49
|
2.80e-01
|
8.93e-02
|
0.613000
|
UNBLOCKING OF NMDA RECEPTORS GLUTAMATE BINDING AND ACTIVATION
|
21
|
4.79e-01
|
8.92e-02
|
0.781000
|
CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE
|
31
|
3.91e-01
|
8.91e-02
|
0.708000
|
PROLACTIN RECEPTOR SIGNALING
|
11
|
6.11e-01
|
-8.86e-02
|
0.845000
|
PHASE 0 RAPID DEPOLARISATION
|
29
|
4.10e-01
|
8.84e-02
|
0.724000
|
METABOLISM OF AMINO ACIDS AND DERIVATIVES
|
314
|
7.21e-03
|
-8.84e-02
|
0.096800
|
FLT3 SIGNALING IN DISEASE
|
27
|
4.27e-01
|
-8.83e-02
|
0.738000
|
IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX
|
10
|
6.30e-01
|
8.81e-02
|
0.859000
|
INTERLEUKIN 7 SIGNALING
|
20
|
4.96e-01
|
8.80e-02
|
0.784000
|
CELL CYCLE
|
593
|
2.75e-04
|
-8.78e-02
|
0.017300
|
PURINE SALVAGE
|
12
|
5.99e-01
|
-8.78e-02
|
0.838000
|
SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE
|
52
|
2.76e-01
|
8.73e-02
|
0.610000
|
OTHER INTERLEUKIN SIGNALING
|
19
|
5.13e-01
|
8.67e-02
|
0.795000
|
AMYLOID FIBER FORMATION
|
57
|
2.59e-01
|
8.64e-02
|
0.584000
|
SIGNALING BY BRAF AND RAF FUSIONS
|
60
|
2.52e-01
|
8.55e-02
|
0.577000
|
SIGNALING BY TGFB FAMILY MEMBERS
|
96
|
1.50e-01
|
-8.52e-02
|
0.452000
|
DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY
|
23
|
4.81e-01
|
-8.50e-02
|
0.781000
|
TRANSLATION OF SARS COV 1 STRUCTURAL PROTEINS
|
28
|
4.37e-01
|
8.49e-02
|
0.744000
|
TELOMERE C STRAND SYNTHESIS INITIATION
|
13
|
5.96e-01
|
-8.48e-02
|
0.838000
|
G1 S SPECIFIC TRANSCRIPTION
|
26
|
4.54e-01
|
-8.48e-02
|
0.758000
|
ONCOGENIC MAPK SIGNALING
|
77
|
1.99e-01
|
8.47e-02
|
0.512000
|
SIGNALING BY NTRKS
|
129
|
9.73e-02
|
8.46e-02
|
0.368000
|
INITIATION OF NUCLEAR ENVELOPE NE REFORMATION
|
17
|
5.46e-01
|
-8.46e-02
|
0.811000
|
TP53 REGULATES TRANSCRIPTION OF GENES INVOLVED IN CYTOCHROME C RELEASE
|
19
|
5.26e-01
|
8.40e-02
|
0.805000
|
RNA POLYMERASE II TRANSCRIPTION TERMINATION
|
65
|
2.42e-01
|
-8.39e-02
|
0.563000
|
FORMATION OF THE EARLY ELONGATION COMPLEX
|
33
|
4.06e-01
|
8.37e-02
|
0.719000
|
CELL CYCLE MITOTIC
|
475
|
1.87e-03
|
-8.36e-02
|
0.043300
|
GAP JUNCTION DEGRADATION
|
11
|
6.31e-01
|
8.36e-02
|
0.859000
|
DAP12 SIGNALING
|
24
|
4.80e-01
|
-8.33e-02
|
0.781000
|
DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING
|
26
|
4.62e-01
|
-8.33e-02
|
0.767000
|
SPHINGOLIPID DE NOVO BIOSYNTHESIS
|
42
|
3.52e-01
|
-8.31e-02
|
0.686000
|
NUCLEOBASE CATABOLISM
|
31
|
4.24e-01
|
-8.31e-02
|
0.734000
|
RESOLUTION OF D LOOP STRUCTURES
|
30
|
4.32e-01
|
-8.30e-02
|
0.743000
|
DEFECTS IN VITAMIN AND COFACTOR METABOLISM
|
20
|
5.23e-01
|
8.25e-02
|
0.802000
|
APOPTOTIC FACTOR MEDIATED RESPONSE
|
18
|
5.46e-01
|
-8.21e-02
|
0.811000
|
DISEASES ASSOCIATED WITH N GLYCOSYLATION OF PROTEINS
|
17
|
5.60e-01
|
8.17e-02
|
0.826000
|
INTEGRIN CELL SURFACE INTERACTIONS
|
71
|
2.34e-01
|
8.17e-02
|
0.556000
|
TNFR1 INDUCED PROAPOPTOTIC SIGNALING
|
12
|
6.24e-01
|
8.17e-02
|
0.856000
|
VEGFR2 MEDIATED CELL PROLIFERATION
|
19
|
5.39e-01
|
-8.15e-02
|
0.811000
|
RHO GTPASES ACTIVATE CIT
|
18
|
5.50e-01
|
8.14e-02
|
0.814000
|
TRANSCRIPTIONAL REGULATION BY VENTX
|
35
|
4.05e-01
|
8.13e-02
|
0.719000
|
MUSCLE CONTRACTION
|
163
|
7.41e-02
|
8.12e-02
|
0.313000
|
TRANSCRIPTION OF E2F TARGETS UNDER NEGATIVE CONTROL BY P107 RBL1 AND P130 RBL2 IN COMPLEX WITH HDAC1
|
15
|
5.87e-01
|
-8.10e-02
|
0.835000
|
REGULATION OF TP53 ACTIVITY THROUGH PHOSPHORYLATION
|
87
|
1.92e-01
|
-8.10e-02
|
0.502000
|
INWARDLY RECTIFYING K CHANNELS
|
31
|
4.35e-01
|
-8.09e-02
|
0.744000
|
ACYL CHAIN REMODELLING OF PG
|
10
|
6.58e-01
|
-8.08e-02
|
0.878000
|
METABOLISM OF VITAMINS AND COFACTORS
|
150
|
8.84e-02
|
8.07e-02
|
0.353000
|
GLUCAGON TYPE LIGAND RECEPTORS
|
25
|
4.85e-01
|
-8.06e-02
|
0.782000
|
DAG AND IP3 SIGNALING
|
40
|
3.79e-01
|
8.05e-02
|
0.697000
|
PECAM1 INTERACTIONS
|
12
|
6.30e-01
|
8.02e-02
|
0.859000
|
RECOGNITION AND ASSOCIATION OF DNA GLYCOSYLASE WITH SITE CONTAINING AN AFFECTED PURINE
|
22
|
5.15e-01
|
8.02e-02
|
0.795000
|
INTERLEUKIN 1 SIGNALING
|
96
|
1.75e-01
|
-8.02e-02
|
0.479000
|
LDL CLEARANCE
|
16
|
5.79e-01
|
8.01e-02
|
0.832000
|
GLYOXYLATE METABOLISM AND GLYCINE DEGRADATION
|
25
|
4.89e-01
|
-7.99e-02
|
0.782000
|
GLYCOSPHINGOLIPID METABOLISM
|
39
|
3.88e-01
|
7.98e-02
|
0.708000
|
INSULIN RECEPTOR RECYCLING
|
20
|
5.37e-01
|
-7.97e-02
|
0.811000
|
PROCESSING OF CAPPED INTRONLESS PRE MRNA
|
28
|
4.69e-01
|
-7.91e-02
|
0.772000
|
REGULATION OF LIPID METABOLISM BY PPARALPHA
|
107
|
1.58e-01
|
7.91e-02
|
0.465000
|
GOLGI TO ER RETROGRADE TRANSPORT
|
119
|
1.37e-01
|
7.90e-02
|
0.435000
|
RAP1 SIGNALLING
|
15
|
5.97e-01
|
-7.89e-02
|
0.838000
|
HIV LIFE CYCLE
|
142
|
1.05e-01
|
-7.88e-02
|
0.382000
|
CYTOKINE SIGNALING IN IMMUNE SYSTEM
|
544
|
1.78e-03
|
-7.86e-02
|
0.043300
|
CD209 DC SIGN SIGNALING
|
18
|
5.64e-01
|
-7.85e-02
|
0.827000
|
RUNX1 REGULATES TRANSCRIPTION OF GENES INVOLVED IN DIFFERENTIATION OF HSCS
|
84
|
2.14e-01
|
-7.85e-02
|
0.526000
|
CELL CELL COMMUNICATION
|
107
|
1.61e-01
|
7.84e-02
|
0.466000
|
RNA POLYMERASE II TRANSCRIBES SNRNA GENES
|
74
|
2.47e-01
|
-7.79e-02
|
0.568000
|
REGULATION OF LOCALIZATION OF FOXO TRANSCRIPTION FACTORS
|
12
|
6.41e-01
|
7.79e-02
|
0.867000
|
ADP SIGNALLING THROUGH P2Y PURINOCEPTOR 1
|
23
|
5.18e-01
|
-7.78e-02
|
0.797000
|
RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES
|
85
|
2.16e-01
|
7.77e-02
|
0.529000
|
INTERLEUKIN 35 SIGNALLING
|
10
|
6.74e-01
|
-7.69e-02
|
0.881000
|
CONSTITUTIVE SIGNALING BY LIGAND RESPONSIVE EGFR CANCER VARIANTS
|
19
|
5.64e-01
|
-7.64e-02
|
0.827000
|
SIGNALING BY GPCR
|
462
|
5.23e-03
|
7.60e-02
|
0.077500
|
ERK MAPK TARGETS
|
22
|
5.39e-01
|
7.57e-02
|
0.811000
|
FOXO MEDIATED TRANSCRIPTION OF CELL CYCLE GENES
|
16
|
6.00e-01
|
-7.57e-02
|
0.838000
|
NONHOMOLOGOUS END JOINING NHEJ
|
43
|
3.92e-01
|
-7.55e-02
|
0.708000
|
SHC1 EVENTS IN ERBB2 SIGNALING
|
20
|
5.61e-01
|
-7.50e-02
|
0.827000
|
RHO GTPASE CYCLE
|
422
|
8.56e-03
|
7.48e-02
|
0.103000
|
RNA POLYMERASE II TRANSCRIPTION
|
1085
|
3.97e-05
|
-7.44e-02
|
0.004220
|
RRNA PROCESSING IN THE MITOCHONDRION
|
10
|
6.84e-01
|
-7.44e-02
|
0.884000
|
MITOTIC PROMETAPHASE
|
176
|
8.92e-02
|
-7.44e-02
|
0.354000
|
SIGNALING BY NTRK3 TRKC
|
17
|
5.98e-01
|
7.39e-02
|
0.838000
|
BETA OXIDATION OF VERY LONG CHAIN FATTY ACIDS
|
11
|
6.72e-01
|
7.37e-02
|
0.881000
|
HCMV LATE EVENTS
|
65
|
3.07e-01
|
7.33e-02
|
0.647000
|
CYTOSOLIC SENSORS OF PATHOGEN ASSOCIATED DNA
|
59
|
3.32e-01
|
7.30e-02
|
0.668000
|
RHO GTPASES ACTIVATE KTN1
|
11
|
6.76e-01
|
-7.27e-02
|
0.881000
|
RRNA MODIFICATION IN THE NUCLEUS AND CYTOSOL
|
59
|
3.35e-01
|
-7.25e-02
|
0.670000
|
CONDENSATION OF PROPHASE CHROMOSOMES
|
27
|
5.14e-01
|
-7.25e-02
|
0.795000
|
NEGATIVE REGULATION OF MET ACTIVITY
|
21
|
5.66e-01
|
-7.23e-02
|
0.827000
|
REGULATION OF PTEN GENE TRANSCRIPTION
|
58
|
3.42e-01
|
7.21e-02
|
0.675000
|
TGF BETA RECEPTOR SIGNALING ACTIVATES SMADS
|
32
|
4.80e-01
|
-7.21e-02
|
0.781000
|
GENERATION OF SECOND MESSENGER MOLECULES
|
19
|
5.87e-01
|
-7.21e-02
|
0.835000
|
TRANSCRIPTIONAL REGULATION BY SMALL RNAS
|
61
|
3.31e-01
|
7.20e-02
|
0.668000
|
KERATAN SULFATE DEGRADATION
|
11
|
6.80e-01
|
7.19e-02
|
0.882000
|
NUCLEAR EVENTS KINASE AND TRANSCRIPTION FACTOR ACTIVATION
|
59
|
3.40e-01
|
7.18e-02
|
0.675000
|
ACTIVATION OF BH3 ONLY PROTEINS
|
30
|
4.97e-01
|
-7.16e-02
|
0.784000
|
NGF STIMULATED TRANSCRIPTION
|
37
|
4.54e-01
|
7.12e-02
|
0.758000
|
EPH EPHRIN SIGNALING
|
92
|
2.39e-01
|
7.11e-02
|
0.561000
|
ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION
|
286
|
4.05e-02
|
-7.06e-02
|
0.243000
|
SIGNALING BY HEDGEHOG
|
142
|
1.49e-01
|
7.03e-02
|
0.452000
|
SYNTHESIS OF PC
|
25
|
5.46e-01
|
6.98e-02
|
0.811000
|
PLATELET HOMEOSTASIS
|
78
|
2.89e-01
|
-6.94e-02
|
0.627000
|
BINDING AND UPTAKE OF LIGANDS BY SCAVENGER RECEPTORS
|
31
|
5.04e-01
|
6.94e-02
|
0.786000
|
PURINERGIC SIGNALING IN LEISHMANIASIS INFECTION
|
23
|
5.65e-01
|
-6.93e-02
|
0.827000
|
TRNA AMINOACYLATION
|
42
|
4.39e-01
|
6.91e-02
|
0.744000
|
INTERLEUKIN RECEPTOR SHC SIGNALING
|
20
|
5.93e-01
|
6.91e-02
|
0.838000
|
SIGNALING BY SCF KIT
|
41
|
4.44e-01
|
-6.91e-02
|
0.750000
|
SIGNALING BY EGFR
|
46
|
4.18e-01
|
6.90e-02
|
0.728000
|
CELLULAR SENESCENCE
|
141
|
1.58e-01
|
6.89e-02
|
0.465000
|
PEROXISOMAL PROTEIN IMPORT
|
57
|
3.69e-01
|
-6.89e-02
|
0.695000
|
ACTIVATION OF THE AP 1 FAMILY OF TRANSCRIPTION FACTORS
|
10
|
7.06e-01
|
-6.88e-02
|
0.895000
|
GLYCOLYSIS
|
66
|
3.34e-01
|
6.88e-02
|
0.669000
|
NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE
|
17
|
6.24e-01
|
6.87e-02
|
0.856000
|
ASYMMETRIC LOCALIZATION OF PCP PROTEINS
|
63
|
3.46e-01
|
-6.87e-02
|
0.678000
|
SYNTHESIS OF BILE ACIDS AND BILE SALTS
|
22
|
5.79e-01
|
6.84e-02
|
0.832000
|
UB SPECIFIC PROCESSING PROTEASES
|
169
|
1.28e-01
|
-6.80e-02
|
0.418000
|
SUMOYLATION
|
161
|
1.37e-01
|
-6.80e-02
|
0.435000
|
RNA POLYMERASE III TRANSCRIPTION TERMINATION
|
23
|
5.73e-01
|
-6.79e-02
|
0.831000
|
NEURONAL SYSTEM
|
366
|
2.66e-02
|
6.76e-02
|
0.181000
|
CELLULAR RESPONSE TO CHEMICAL STRESS
|
150
|
1.53e-01
|
-6.76e-02
|
0.460000
|
SIGNALING BY ERYTHROPOIETIN
|
24
|
5.67e-01
|
6.75e-02
|
0.827000
|
RESPONSE OF MTB TO PHAGOCYTOSIS
|
21
|
5.94e-01
|
6.72e-02
|
0.838000
|
MET PROMOTES CELL MOTILITY
|
39
|
4.69e-01
|
6.70e-02
|
0.772000
|
MAP3K8 TPL2 DEPENDENT MAPK1 3 ACTIVATION
|
16
|
6.43e-01
|
6.68e-02
|
0.870000
|
RAS PROCESSING
|
24
|
5.71e-01
|
-6.68e-02
|
0.829000
|
CYTOPROTECTION BY HMOX1
|
120
|
2.09e-01
|
-6.64e-02
|
0.522000
|
INTRAFLAGELLAR TRANSPORT
|
50
|
4.18e-01
|
6.62e-02
|
0.728000
|
SUMOYLATION OF TRANSCRIPTION COFACTORS
|
42
|
4.59e-01
|
6.60e-02
|
0.765000
|
RHOJ GTPASE CYCLE
|
54
|
4.04e-01
|
-6.57e-02
|
0.718000
|
POLYMERASE SWITCHING
|
14
|
6.70e-01
|
-6.57e-02
|
0.881000
|
TRIGLYCERIDE METABOLISM
|
23
|
5.87e-01
|
-6.54e-02
|
0.835000
|
DOWNSTREAM SIGNALING OF ACTIVATED FGFR3
|
20
|
6.16e-01
|
-6.49e-02
|
0.849000
|
BIOSYNTHESIS OF SPECIALIZED PRORESOLVING MEDIATORS SPMS
|
12
|
6.99e-01
|
-6.45e-02
|
0.891000
|
SIGNALING BY FGFR IN DISEASE
|
55
|
4.08e-01
|
-6.45e-02
|
0.722000
|
ACETYLCHOLINE BINDING AND DOWNSTREAM EVENTS
|
10
|
7.24e-01
|
-6.44e-02
|
0.896000
|
HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS
|
10
|
7.24e-01
|
-6.44e-02
|
0.896000
|
ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT
|
30
|
5.42e-01
|
-6.44e-02
|
0.811000
|
AUTOPHAGY
|
137
|
1.94e-01
|
6.43e-02
|
0.505000
|
ERBB2 ACTIVATES PTK6 SIGNALING
|
10
|
7.25e-01
|
6.43e-02
|
0.896000
|
PLATELET CALCIUM HOMEOSTASIS
|
27
|
5.64e-01
|
6.41e-02
|
0.827000
|
SIGNALING BY NOTCH4
|
83
|
3.14e-01
|
-6.39e-02
|
0.654000
|
LATE ENDOSOMAL MICROAUTOPHAGY
|
30
|
5.45e-01
|
6.38e-02
|
0.811000
|
N GLYCAN ANTENNAE ELONGATION
|
15
|
6.69e-01
|
6.37e-02
|
0.881000
|
CHROMOSOME MAINTENANCE
|
101
|
2.71e-01
|
-6.34e-02
|
0.601000
|
METABOLISM OF NITRIC OXIDE NOS3 ACTIVATION AND REGULATION
|
15
|
6.76e-01
|
-6.24e-02
|
0.881000
|
TRAF3 DEPENDENT IRF ACTIVATION PATHWAY
|
13
|
6.98e-01
|
6.22e-02
|
0.891000
|
SIGNALING BY RHO GTPASES MIRO GTPASES AND RHOBTB3
|
622
|
8.61e-03
|
6.20e-02
|
0.103000
|
PI3K EVENTS IN ERBB2 SIGNALING
|
14
|
6.88e-01
|
-6.19e-02
|
0.885000
|
YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION
|
11
|
7.23e-01
|
6.17e-02
|
0.896000
|
ANTIMICROBIAL PEPTIDES
|
12
|
7.11e-01
|
6.17e-02
|
0.896000
|
RESOLUTION OF AP SITES VIA THE MULTIPLE NUCLEOTIDE PATCH REPLACEMENT PATHWAY
|
25
|
5.95e-01
|
-6.15e-02
|
0.838000
|
EGFR DOWNREGULATION
|
27
|
5.81e-01
|
6.14e-02
|
0.832000
|
ANTIGEN ACTIVATES B CELL RECEPTOR BCR LEADING TO GENERATION OF SECOND MESSENGERS
|
26
|
5.88e-01
|
-6.14e-02
|
0.835000
|
DEVELOPMENTAL BIOLOGY
|
813
|
3.09e-03
|
6.14e-02
|
0.057500
|
NEDDYLATION
|
218
|
1.20e-01
|
-6.12e-02
|
0.411000
|
TRANSCRIPTIONAL ACTIVITY OF SMAD2 SMAD3 SMAD4 HETEROTRIMER
|
43
|
4.89e-01
|
-6.10e-02
|
0.782000
|
DISORDERS OF TRANSMEMBRANE TRANSPORTERS
|
143
|
2.11e-01
|
-6.06e-02
|
0.524000
|
ADAPTIVE IMMUNE SYSTEM
|
599
|
1.18e-02
|
-6.05e-02
|
0.114000
|
SUMOYLATION OF TRANSCRIPTION FACTORS
|
16
|
6.76e-01
|
-6.04e-02
|
0.881000
|
FOXO MEDIATED TRANSCRIPTION
|
57
|
4.37e-01
|
-5.96e-02
|
0.744000
|
REGULATION OF INSULIN LIKE GROWTH FACTOR IGF TRANSPORT AND UPTAKE BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS
|
89
|
3.32e-01
|
5.96e-02
|
0.668000
|
POSITIVE EPIGENETIC REGULATION OF RRNA EXPRESSION
|
62
|
4.18e-01
|
5.95e-02
|
0.728000
|
IRAK1 RECRUITS IKK COMPLEX
|
14
|
7.00e-01
|
5.94e-02
|
0.892000
|
INTERACTIONS OF REV WITH HOST CELLULAR PROTEINS
|
35
|
5.44e-01
|
-5.93e-02
|
0.811000
|
POTENTIAL THERAPEUTICS FOR SARS
|
77
|
3.72e-01
|
5.88e-02
|
0.695000
|
ASPARAGINE N LINKED GLYCOSYLATION
|
282
|
9.02e-02
|
5.88e-02
|
0.354000
|
SIGNALING BY NODAL
|
16
|
6.86e-01
|
5.84e-02
|
0.884000
|
PROTEIN LOCALIZATION
|
156
|
2.09e-01
|
-5.84e-02
|
0.522000
|
APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS
|
34
|
5.56e-01
|
-5.83e-02
|
0.822000
|
ERYTHROPOIETIN ACTIVATES RAS
|
13
|
7.17e-01
|
-5.80e-02
|
0.896000
|
REGULATION OF IFNA SIGNALING
|
12
|
7.28e-01
|
5.80e-02
|
0.897000
|
ERBB2 REGULATES CELL MOTILITY
|
13
|
7.20e-01
|
-5.75e-02
|
0.896000
|
TP53 REGULATES METABOLIC GENES
|
85
|
3.64e-01
|
-5.70e-02
|
0.695000
|
TICAM1 DEPENDENT ACTIVATION OF IRF3 IRF7
|
12
|
7.33e-01
|
5.68e-02
|
0.900000
|
RHOD GTPASE CYCLE
|
50
|
4.88e-01
|
-5.68e-02
|
0.782000
|
CLASS B 2 SECRETIN FAMILY RECEPTORS
|
70
|
4.12e-01
|
5.67e-02
|
0.726000
|
NEUROTOXICITY OF CLOSTRIDIUM TOXINS
|
10
|
7.56e-01
|
-5.67e-02
|
0.910000
|
PTK6 REGULATES RHO GTPASES RAS GTPASE AND MAP KINASES
|
13
|
7.24e-01
|
-5.65e-02
|
0.896000
|
TNFR2 NON CANONICAL NF KB PATHWAY
|
83
|
3.74e-01
|
-5.65e-02
|
0.695000
|
GOLGI CISTERNAE PERICENTRIOLAR STACK REORGANIZATION
|
12
|
7.36e-01
|
-5.63e-02
|
0.900000
|
MTOR SIGNALLING
|
40
|
5.39e-01
|
-5.62e-02
|
0.811000
|
SIGNALING BY FGFR1
|
42
|
5.29e-01
|
-5.62e-02
|
0.807000
|
DNA STRAND ELONGATION
|
32
|
5.85e-01
|
-5.59e-02
|
0.835000
|
METABOLISM OF NUCLEOTIDES
|
92
|
3.56e-01
|
-5.58e-02
|
0.692000
|
TRANSCRIPTIONAL REGULATION OF PLURIPOTENT STEM CELLS
|
16
|
6.99e-01
|
-5.58e-02
|
0.891000
|
TRAF6 MEDIATED NF KB ACTIVATION
|
22
|
6.51e-01
|
5.57e-02
|
0.872000
|
INTRINSIC PATHWAY FOR APOPTOSIS
|
52
|
4.87e-01
|
-5.57e-02
|
0.782000
|
ESTROGEN DEPENDENT NUCLEAR EVENTS DOWNSTREAM OF ESR MEMBRANE SIGNALING
|
20
|
6.67e-01
|
-5.56e-02
|
0.881000
|
SIGNALING BY ACTIVIN
|
12
|
7.39e-01
|
-5.56e-02
|
0.902000
|
VIRAL MESSENGER RNA SYNTHESIS
|
42
|
5.33e-01
|
5.56e-02
|
0.810000
|
ION TRANSPORT BY P TYPE ATPASES
|
48
|
5.06e-01
|
5.55e-02
|
0.786000
|
POTASSIUM CHANNELS
|
90
|
3.63e-01
|
5.55e-02
|
0.695000
|
OPIOID SIGNALLING
|
86
|
3.76e-01
|
-5.52e-02
|
0.695000
|
RHOF GTPASE CYCLE
|
40
|
5.46e-01
|
-5.52e-02
|
0.811000
|
ERYTHROPOIETIN ACTIVATES PHOSPHOINOSITIDE 3 KINASE PI3K
|
11
|
7.51e-01
|
5.51e-02
|
0.906000
|
PI3K AKT SIGNALING IN CANCER
|
87
|
3.76e-01
|
5.50e-02
|
0.695000
|
NEUTROPHIL DEGRANULATION
|
384
|
6.71e-02
|
-5.46e-02
|
0.305000
|
THE NLRP3 INFLAMMASOME
|
15
|
7.17e-01
|
-5.41e-02
|
0.896000
|
RNA POLYMERASE I TRANSCRIPTION TERMINATION
|
31
|
6.02e-01
|
-5.41e-02
|
0.838000
|
SIGNALING BY NOTCH
|
189
|
2.01e-01
|
5.40e-02
|
0.513000
|
PARASITE INFECTION
|
54
|
4.93e-01
|
5.39e-02
|
0.782000
|
NEGATIVE REGULATION OF FGFR3 SIGNALING
|
24
|
6.48e-01
|
5.39e-02
|
0.871000
|
RHOV GTPASE CYCLE
|
32
|
5.98e-01
|
-5.38e-02
|
0.838000
|
ANTI INFLAMMATORY RESPONSE FAVOURING LEISHMANIA PARASITE INFECTION
|
110
|
3.32e-01
|
5.35e-02
|
0.668000
|
ALPHA LINOLENIC OMEGA3 AND LINOLEIC OMEGA6 ACID METABOLISM
|
12
|
7.48e-01
|
5.35e-02
|
0.905000
|
MRNA SPLICING MINOR PATHWAY
|
52
|
5.05e-01
|
5.34e-02
|
0.786000
|
INTERLEUKIN 2 FAMILY SIGNALING
|
32
|
6.01e-01
|
5.34e-02
|
0.838000
|
SIGNALING BY INSULIN RECEPTOR
|
61
|
4.72e-01
|
-5.33e-02
|
0.774000
|
OVARIAN TUMOR DOMAIN PROTEASES
|
36
|
5.80e-01
|
-5.33e-02
|
0.832000
|
MAPK FAMILY SIGNALING CASCADES
|
286
|
1.22e-01
|
5.33e-02
|
0.413000
|
NUCLEOTIDE SALVAGE
|
21
|
6.75e-01
|
5.29e-02
|
0.881000
|
RAB REGULATION OF TRAFFICKING
|
119
|
3.20e-01
|
5.28e-02
|
0.659000
|
CTLA4 INHIBITORY SIGNALING
|
20
|
6.83e-01
|
-5.28e-02
|
0.884000
|
MHC CLASS II ANTIGEN PRESENTATION
|
102
|
3.58e-01
|
5.28e-02
|
0.694000
|
MITOCHONDRIAL TRANSLATION
|
93
|
3.82e-01
|
-5.25e-02
|
0.699000
|
CHEMOKINE RECEPTORS BIND CHEMOKINES
|
17
|
7.08e-01
|
-5.24e-02
|
0.895000
|
MITOTIC G2 G2 M PHASES
|
186
|
2.18e-01
|
-5.24e-02
|
0.532000
|
MITOPHAGY
|
29
|
6.27e-01
|
-5.22e-02
|
0.857000
|
GLYCOGEN BREAKDOWN GLYCOGENOLYSIS
|
14
|
7.38e-01
|
-5.17e-02
|
0.902000
|
HEME SIGNALING
|
45
|
5.49e-01
|
-5.17e-02
|
0.813000
|
COPII MEDIATED VESICLE TRANSPORT
|
64
|
4.75e-01
|
5.16e-02
|
0.778000
|
MITOTIC PROPHASE
|
94
|
3.88e-01
|
-5.15e-02
|
0.708000
|
SIGNALING BY ERBB2
|
47
|
5.43e-01
|
-5.13e-02
|
0.811000
|
IRS MEDIATED SIGNALLING
|
37
|
5.90e-01
|
-5.12e-02
|
0.837000
|
HEDGEHOG OFF STATE
|
107
|
3.61e-01
|
5.11e-02
|
0.695000
|
SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS
|
62
|
4.87e-01
|
5.11e-02
|
0.782000
|
SNRNP ASSEMBLY
|
51
|
5.30e-01
|
-5.09e-02
|
0.807000
|
DOWNREGULATION OF ERBB2 SIGNALING
|
27
|
6.48e-01
|
5.08e-02
|
0.871000
|
CELL JUNCTION ORGANIZATION
|
75
|
4.52e-01
|
5.03e-02
|
0.758000
|
DCC MEDIATED ATTRACTIVE SIGNALING
|
14
|
7.46e-01
|
5.00e-02
|
0.903000
|
GLOBAL GENOME NUCLEOTIDE EXCISION REPAIR GG NER
|
84
|
4.33e-01
|
-4.96e-02
|
0.743000
|
INTERLEUKIN 1 FAMILY SIGNALING
|
122
|
3.45e-01
|
-4.95e-02
|
0.677000
|
DEUBIQUITINATION
|
243
|
1.88e-01
|
-4.91e-02
|
0.495000
|
PROCESSIVE SYNTHESIS ON THE LAGGING STRAND
|
15
|
7.42e-01
|
-4.90e-02
|
0.903000
|
INTRA GOLGI AND RETROGRADE GOLGI TO ER TRAFFIC
|
185
|
2.51e-01
|
4.90e-02
|
0.575000
|
SIGNAL TRANSDUCTION BY L1
|
21
|
6.98e-01
|
4.90e-02
|
0.891000
|
TRANSFERRIN ENDOCYTOSIS AND RECYCLING
|
26
|
6.66e-01
|
-4.89e-02
|
0.881000
|
RECEPTOR TYPE TYROSINE PROTEIN PHOSPHATASES
|
20
|
7.06e-01
|
4.88e-02
|
0.895000
|
SIGNALING BY NTRK2 TRKB
|
24
|
6.79e-01
|
-4.87e-02
|
0.882000
|
SIGNALING BY RETINOIC ACID
|
34
|
6.25e-01
|
-4.84e-02
|
0.857000
|
REGULATION OF HSF1 MEDIATED HEAT SHOCK RESPONSE
|
77
|
4.65e-01
|
-4.82e-02
|
0.769000
|
THE ROLE OF NEF IN HIV 1 REPLICATION AND DISEASE PATHOGENESIS
|
25
|
6.77e-01
|
-4.81e-02
|
0.881000
|
BETA CATENIN INDEPENDENT WNT SIGNALING
|
139
|
3.28e-01
|
-4.81e-02
|
0.667000
|
SIGNALING BY RECEPTOR TYROSINE KINASES
|
459
|
8.07e-02
|
4.77e-02
|
0.335000
|
GPVI MEDIATED ACTIVATION CASCADE
|
31
|
6.46e-01
|
4.77e-02
|
0.870000
|
CHAPERONE MEDIATED AUTOPHAGY
|
19
|
7.21e-01
|
-4.73e-02
|
0.896000
|
HDR THROUGH MMEJ ALT NHEJ
|
10
|
7.96e-01
|
-4.72e-02
|
0.929000
|
INTERLEUKIN 3 INTERLEUKIN 5 AND GM CSF SIGNALING
|
41
|
6.02e-01
|
4.71e-02
|
0.838000
|
GLYCOGEN METABOLISM
|
25
|
6.85e-01
|
-4.70e-02
|
0.884000
|
TRANSCRIPTIONAL REGULATION BY RUNX1
|
179
|
2.79e-01
|
4.69e-02
|
0.613000
|
CA DEPENDENT EVENTS
|
36
|
6.27e-01
|
4.68e-02
|
0.857000
|
HEMOSTASIS
|
474
|
8.33e-02
|
4.66e-02
|
0.339000
|
CLATHRIN MEDIATED ENDOCYTOSIS
|
130
|
3.60e-01
|
4.66e-02
|
0.695000
|
SIGNALING BY TGF BETA RECEPTOR COMPLEX
|
72
|
4.95e-01
|
-4.65e-02
|
0.784000
|
SUMOYLATION OF DNA REPLICATION PROTEINS
|
43
|
5.98e-01
|
-4.64e-02
|
0.838000
|
HYALURONAN UPTAKE AND DEGRADATION
|
11
|
7.90e-01
|
4.64e-02
|
0.929000
|
EXTENSION OF TELOMERES
|
49
|
5.77e-01
|
-4.61e-02
|
0.832000
|
HIV TRANSCRIPTION ELONGATION
|
42
|
6.05e-01
|
4.61e-02
|
0.841000
|
EGR2 AND SOX10 MEDIATED INITIATION OF SCHWANN CELL MYELINATION
|
27
|
6.80e-01
|
4.59e-02
|
0.882000
|
RESPONSE OF EIF2AK1 HRI TO HEME DEFICIENCY
|
14
|
7.66e-01
|
-4.59e-02
|
0.916000
|
SIGNALING BY INTERLEUKINS
|
348
|
1.44e-01
|
-4.56e-02
|
0.445000
|
ACTIVATED PKN1 STIMULATES TRANSCRIPTION OF AR ANDROGEN RECEPTOR REGULATED GENES KLK2 AND KLK3
|
21
|
7.18e-01
|
4.56e-02
|
0.896000
|
INSULIN RECEPTOR SIGNALLING CASCADE
|
42
|
6.10e-01
|
-4.56e-02
|
0.845000
|
TIGHT JUNCTION INTERACTIONS
|
20
|
7.26e-01
|
4.52e-02
|
0.896000
|
INHIBITION OF DNA RECOMBINATION AT TELOMERE
|
35
|
6.44e-01
|
4.52e-02
|
0.870000
|
NERVOUS SYSTEM DEVELOPMENT
|
547
|
7.17e-02
|
4.52e-02
|
0.311000
|
INTERLEUKIN 27 SIGNALING
|
10
|
8.05e-01
|
4.50e-02
|
0.935000
|
SIGNALING BY MET
|
75
|
5.01e-01
|
4.50e-02
|
0.786000
|
RHO GTPASES ACTIVATE ROCKS
|
19
|
7.35e-01
|
4.49e-02
|
0.900000
|
MAPK TARGETS NUCLEAR EVENTS MEDIATED BY MAP KINASES
|
31
|
6.69e-01
|
-4.44e-02
|
0.881000
|
NUCLEAR SIGNALING BY ERBB4
|
30
|
6.74e-01
|
4.44e-02
|
0.881000
|
SUMOYLATION OF SUMOYLATION PROTEINS
|
33
|
6.61e-01
|
-4.42e-02
|
0.880000
|
RHO GTPASES ACTIVATE PKNS
|
47
|
6.01e-01
|
-4.41e-02
|
0.838000
|
EPHB MEDIATED FORWARD SIGNALING
|
42
|
6.22e-01
|
4.40e-02
|
0.855000
|
AQUAPORIN MEDIATED TRANSPORT
|
40
|
6.33e-01
|
-4.37e-02
|
0.860000
|
LEISHMANIA INFECTION
|
189
|
3.03e-01
|
4.35e-02
|
0.645000
|
SUPPRESSION OF PHAGOSOMAL MATURATION
|
12
|
7.95e-01
|
-4.32e-02
|
0.929000
|
THE CANONICAL RETINOID CYCLE IN RODS TWILIGHT VISION
|
14
|
7.81e-01
|
4.29e-02
|
0.928000
|
VASOPRESSIN REGULATES RENAL WATER HOMEOSTASIS VIA AQUAPORINS
|
37
|
6.54e-01
|
-4.27e-02
|
0.874000
|
SIGNALING BY VEGF
|
101
|
4.60e-01
|
4.26e-02
|
0.765000
|
NUCLEOBASE BIOSYNTHESIS
|
15
|
7.75e-01
|
4.26e-02
|
0.924000
|
VEGFR2 MEDIATED VASCULAR PERMEABILITY
|
26
|
7.08e-01
|
-4.24e-02
|
0.895000
|
GLUCAGON LIKE PEPTIDE 1 GLP1 REGULATES INSULIN SECRETION
|
38
|
6.55e-01
|
-4.20e-02
|
0.874000
|
MECP2 REGULATES NEURONAL RECEPTORS AND CHANNELS
|
18
|
7.59e-01
|
-4.18e-02
|
0.911000
|
SIGNALING BY EGFR IN CANCER
|
21
|
7.40e-01
|
-4.18e-02
|
0.902000
|
RHOG GTPASE CYCLE
|
73
|
5.42e-01
|
4.13e-02
|
0.811000
|
FCGR3A MEDIATED IL10 SYNTHESIS
|
32
|
6.86e-01
|
4.13e-02
|
0.884000
|
COMPLEMENT CASCADE
|
24
|
7.31e-01
|
-4.05e-02
|
0.900000
|
DNA DAMAGE TELOMERE STRESS INDUCED SENESCENCE
|
43
|
6.46e-01
|
-4.05e-02
|
0.870000
|
TRANSPORT OF BILE SALTS AND ORGANIC ACIDS METAL IONS AND AMINE COMPOUNDS
|
63
|
5.80e-01
|
-4.03e-02
|
0.832000
|
THE ROLE OF GTSE1 IN G2 M PROGRESSION AFTER G2 CHECKPOINT
|
68
|
5.68e-01
|
-4.01e-02
|
0.827000
|
DUAL INCISION IN TC NER
|
65
|
5.77e-01
|
-4.00e-02
|
0.832000
|
ACYL CHAIN REMODELLING OF PC
|
17
|
7.76e-01
|
3.99e-02
|
0.924000
|
SIGNALLING TO ERKS
|
32
|
6.99e-01
|
3.95e-02
|
0.891000
|
GLUCAGON SIGNALING IN METABOLIC REGULATION
|
29
|
7.14e-01
|
-3.94e-02
|
0.896000
|
INSERTION OF TAIL ANCHORED PROTEINS INTO THE ENDOPLASMIC RETICULUM MEMBRANE
|
22
|
7.49e-01
|
3.93e-02
|
0.905000
|
INNATE IMMUNE SYSTEM
|
773
|
6.47e-02
|
-3.93e-02
|
0.303000
|
RNA POLYMERASE III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER
|
28
|
7.20e-01
|
-3.92e-02
|
0.896000
|
SIRT1 NEGATIVELY REGULATES RRNA EXPRESSION
|
24
|
7.41e-01
|
-3.90e-02
|
0.902000
|
NICOTINAMIDE SALVAGING
|
15
|
7.97e-01
|
-3.84e-02
|
0.929000
|
PLATELET SENSITIZATION BY LDL
|
15
|
7.99e-01
|
-3.80e-02
|
0.930000
|
HSF1 ACTIVATION
|
27
|
7.33e-01
|
3.79e-02
|
0.900000
|
ESR MEDIATED SIGNALING
|
163
|
4.07e-01
|
-3.77e-02
|
0.720000
|
GPCR LIGAND BINDING
|
247
|
3.09e-01
|
3.76e-02
|
0.649000
|
PHASE I FUNCTIONALIZATION OF COMPOUNDS
|
58
|
6.22e-01
|
3.74e-02
|
0.855000
|
ROLE OF SECOND MESSENGERS IN NETRIN 1 SIGNALING
|
10
|
8.38e-01
|
-3.73e-02
|
0.949000
|
REGULATION OF FOXO TRANSCRIPTIONAL ACTIVITY BY ACETYLATION
|
10
|
8.38e-01
|
-3.73e-02
|
0.949000
|
SUMOYLATION OF RNA BINDING PROTEINS
|
45
|
6.66e-01
|
-3.72e-02
|
0.881000
|
TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING
|
13
|
8.18e-01
|
3.68e-02
|
0.945000
|
INFECTIOUS DISEASE
|
722
|
9.62e-02
|
-3.65e-02
|
0.366000
|
TRANSPORT OF SMALL MOLECULES
|
569
|
1.39e-01
|
3.65e-02
|
0.437000
|
HSP90 CHAPERONE CYCLE FOR STEROID HORMONE RECEPTORS SHR
|
48
|
6.62e-01
|
3.64e-02
|
0.881000
|
RNA POLYMERASE I TRANSCRIPTION INITIATION
|
47
|
6.66e-01
|
3.64e-02
|
0.881000
|
CREB1 PHOSPHORYLATION THROUGH NMDA RECEPTOR MEDIATED ACTIVATION OF RAS SIGNALING
|
28
|
7.39e-01
|
3.64e-02
|
0.902000
|
G PROTEIN MEDIATED EVENTS
|
52
|
6.52e-01
|
3.62e-02
|
0.872000
|
NUCLEAR ENVELOPE NE REASSEMBLY
|
64
|
6.22e-01
|
3.57e-02
|
0.855000
|
NOD1 2 SIGNALING PATHWAY
|
34
|
7.19e-01
|
3.56e-02
|
0.896000
|
RHO GTPASES ACTIVATE WASPS AND WAVES
|
36
|
7.14e-01
|
-3.53e-02
|
0.896000
|
NEGATIVE REGULATION OF FGFR1 SIGNALING
|
25
|
7.60e-01
|
3.53e-02
|
0.911000
|
RHOQ GTPASE CYCLE
|
57
|
6.46e-01
|
3.51e-02
|
0.870000
|
RECEPTOR MEDIATED MITOPHAGY
|
11
|
8.40e-01
|
-3.51e-02
|
0.949000
|
VXPX CARGO TARGETING TO CILIUM
|
19
|
7.92e-01
|
-3.50e-02
|
0.929000
|
TRANSCRIPTIONAL REGULATION BY RUNX3
|
92
|
5.68e-01
|
-3.45e-02
|
0.827000
|
METABOLISM OF STEROIDS
|
112
|
5.30e-01
|
-3.43e-02
|
0.807000
|
CELLULAR RESPONSES TO EXTERNAL STIMULI
|
600
|
1.55e-01
|
-3.41e-02
|
0.462000
|
RHO GTPASES ACTIVATE FORMINS
|
118
|
5.26e-01
|
-3.39e-02
|
0.805000
|
CELL CELL JUNCTION ORGANIZATION
|
51
|
6.76e-01
|
-3.38e-02
|
0.881000
|
FORMATION OF TC NER PRE INCISION COMPLEX
|
53
|
6.71e-01
|
-3.38e-02
|
0.881000
|
ARACHIDONIC ACID METABOLISM
|
39
|
7.17e-01
|
3.36e-02
|
0.896000
|
RHO GTPASES ACTIVATE PAKS
|
21
|
7.90e-01
|
-3.36e-02
|
0.929000
|
MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE
|
15
|
8.25e-01
|
-3.30e-02
|
0.946000
|
GENE SILENCING BY RNA
|
83
|
6.10e-01
|
3.24e-02
|
0.845000
|
VESICLE MEDIATED TRANSPORT
|
605
|
1.76e-01
|
3.23e-02
|
0.480000
|
METABOLISM OF STEROID HORMONES
|
20
|
8.03e-01
|
-3.22e-02
|
0.933000
|
FATTY ACID METABOLISM
|
145
|
5.04e-01
|
-3.22e-02
|
0.786000
|
SIGNALING BY WNT IN CANCER
|
30
|
7.61e-01
|
3.21e-02
|
0.912000
|
COBALAMIN CBL VITAMIN B12 TRANSPORT AND METABOLISM
|
13
|
8.42e-01
|
3.19e-02
|
0.949000
|
SURFACTANT METABOLISM
|
17
|
8.21e-01
|
3.17e-02
|
0.946000
|
G ALPHA Z SIGNALLING EVENTS
|
45
|
7.14e-01
|
-3.16e-02
|
0.896000
|
DISEASES OF IMMUNE SYSTEM
|
24
|
7.89e-01
|
3.16e-02
|
0.929000
|
TRANSCRIPTIONAL ACTIVATION OF MITOCHONDRIAL BIOGENESIS
|
54
|
6.88e-01
|
3.16e-02
|
0.885000
|
METABOLISM OF LIPIDS
|
610
|
1.86e-01
|
3.15e-02
|
0.492000
|
NICOTINATE METABOLISM
|
24
|
7.91e-01
|
3.13e-02
|
0.929000
|
BASIGIN INTERACTIONS
|
23
|
7.97e-01
|
3.10e-02
|
0.929000
|
TRANSMISSION ACROSS CHEMICAL SYNAPSES
|
238
|
4.13e-01
|
3.09e-02
|
0.726000
|
MEMBRANE TRAFFICKING
|
576
|
2.14e-01
|
3.04e-02
|
0.526000
|
ADORA2B MEDIATED ANTI INFLAMMATORY CYTOKINES PRODUCTION
|
85
|
6.30e-01
|
3.03e-02
|
0.859000
|
FGFR2 ALTERNATIVE SPLICING
|
25
|
7.95e-01
|
3.01e-02
|
0.929000
|
ANCHORING OF THE BASAL BODY TO THE PLASMA MEMBRANE
|
96
|
6.12e-01
|
3.00e-02
|
0.845000
|
PHOSPHOLIPASE C MEDIATED CASCADE FGFR2
|
11
|
8.63e-01
|
-3.00e-02
|
0.958000
|
TP53 REGULATES TRANSCRIPTION OF DNA REPAIR GENES
|
61
|
6.93e-01
|
2.93e-02
|
0.889000
|
SIGNALING BY TYPE 1 INSULIN LIKE GROWTH FACTOR 1 RECEPTOR IGF1R
|
41
|
7.46e-01
|
-2.92e-02
|
0.903000
|
FORMATION OF SENESCENCE ASSOCIATED HETEROCHROMATIN FOCI SAHF
|
13
|
8.58e-01
|
-2.87e-02
|
0.956000
|
MRNA CAPPING
|
29
|
7.90e-01
|
-2.86e-02
|
0.929000
|
REGULATION OF KIT SIGNALING
|
16
|
8.46e-01
|
-2.81e-02
|
0.950000
|
NUCLEOTIDE LIKE PURINERGIC RECEPTORS
|
13
|
8.61e-01
|
-2.81e-02
|
0.957000
|
RAB GEFS EXCHANGE GTP FOR GDP ON RABS
|
88
|
6.50e-01
|
-2.80e-02
|
0.872000
|
CARGO CONCENTRATION IN THE ER
|
30
|
7.91e-01
|
2.79e-02
|
0.929000
|
NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS
|
12
|
8.69e-01
|
2.76e-02
|
0.962000
|
RNA POLYMERASE I PROMOTER ESCAPE
|
47
|
7.45e-01
|
-2.74e-02
|
0.903000
|
CYTOSOLIC SULFONATION OF SMALL MOLECULES
|
15
|
8.54e-01
|
2.74e-02
|
0.954000
|
JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1
|
22
|
8.25e-01
|
-2.73e-02
|
0.946000
|
PLATELET ACTIVATION SIGNALING AND AGGREGATION
|
223
|
4.85e-01
|
2.72e-02
|
0.782000
|
BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN
|
76
|
6.83e-01
|
2.71e-02
|
0.884000
|
COOPERATION OF PREFOLDIN AND TRIC CCT IN ACTIN AND TUBULIN FOLDING
|
26
|
8.11e-01
|
2.71e-02
|
0.939000
|
GAP FILLING DNA REPAIR SYNTHESIS AND LIGATION IN GG NER
|
25
|
8.16e-01
|
-2.69e-02
|
0.945000
|
TRANSLATION OF SARS COV 2 STRUCTURAL PROTEINS
|
44
|
7.60e-01
|
2.66e-02
|
0.911000
|
RNA POLYMERASE III CHAIN ELONGATION
|
18
|
8.46e-01
|
-2.64e-02
|
0.950000
|
HOMOLOGY DIRECTED REPAIR
|
108
|
6.37e-01
|
-2.63e-02
|
0.864000
|
RNA POLYMERASE I TRANSCRIPTION
|
67
|
7.12e-01
|
2.61e-02
|
0.896000
|
B WICH COMPLEX POSITIVELY REGULATES RRNA EXPRESSION
|
47
|
7.57e-01
|
2.60e-02
|
0.911000
|
BASE EXCISION REPAIR
|
57
|
7.35e-01
|
2.59e-02
|
0.900000
|
LOSS OF FUNCTION OF MECP2 IN RETT SYNDROME
|
13
|
8.73e-01
|
-2.56e-02
|
0.963000
|
TOLL LIKE RECEPTOR CASCADES
|
138
|
6.06e-01
|
-2.54e-02
|
0.841000
|
REGULATION OF TP53 EXPRESSION AND DEGRADATION
|
35
|
7.95e-01
|
-2.54e-02
|
0.929000
|
METABOLIC DISORDERS OF BIOLOGICAL OXIDATION ENZYMES
|
20
|
8.48e-01
|
2.47e-02
|
0.950000
|
REGULATION OF SIGNALING BY CBL
|
22
|
8.42e-01
|
-2.46e-02
|
0.949000
|
TRANSCRIPTIONAL REGULATION BY TP53
|
342
|
4.36e-01
|
-2.46e-02
|
0.744000
|
TRANSPORT OF MATURE TRANSCRIPT TO CYTOPLASM
|
79
|
7.07e-01
|
-2.45e-02
|
0.895000
|
THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS
|
27
|
8.26e-01
|
-2.45e-02
|
0.946000
|
ACTIVATION OF GENE EXPRESSION BY SREBF SREBP
|
43
|
7.82e-01
|
2.44e-02
|
0.928000
|
GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTEGRINS
|
12
|
8.85e-01
|
2.41e-02
|
0.965000
|
BASE EXCISION REPAIR AP SITE FORMATION
|
29
|
8.24e-01
|
2.38e-02
|
0.946000
|
SIGNALING BY WNT
|
268
|
5.05e-01
|
-2.37e-02
|
0.786000
|
CLASS A 1 RHODOPSIN LIKE RECEPTORS
|
166
|
6.01e-01
|
2.36e-02
|
0.838000
|
NRIF SIGNALS CELL DEATH FROM THE NUCLEUS
|
17
|
8.66e-01
|
2.36e-02
|
0.961000
|
STRIATED MUSCLE CONTRACTION
|
28
|
8.30e-01
|
2.34e-02
|
0.946000
|
SARS COV 1 INFECTION
|
48
|
7.79e-01
|
-2.34e-02
|
0.928000
|
ADRENALINE NORADRENALINE INHIBITS INSULIN SECRETION
|
26
|
8.37e-01
|
2.34e-02
|
0.949000
|
RND1 GTPASE CYCLE
|
37
|
8.10e-01
|
-2.28e-02
|
0.939000
|
RAF ACTIVATION
|
34
|
8.18e-01
|
-2.28e-02
|
0.945000
|
POLO LIKE KINASE MEDIATED EVENTS
|
14
|
8.84e-01
|
-2.26e-02
|
0.965000
|
BIOLOGICAL OXIDATIONS
|
122
|
6.67e-01
|
-2.26e-02
|
0.881000
|
REGULATION OF INSULIN SECRETION
|
71
|
7.44e-01
|
2.24e-02
|
0.903000
|
SCAVENGING BY CLASS A RECEPTORS
|
13
|
8.89e-01
|
2.23e-02
|
0.967000
|
SIGNALING BY NUCLEAR RECEPTORS
|
221
|
5.71e-01
|
-2.22e-02
|
0.829000
|
RAC2 GTPASE CYCLE
|
86
|
7.23e-01
|
-2.21e-02
|
0.896000
|
UCH PROTEINASES
|
90
|
7.18e-01
|
-2.20e-02
|
0.896000
|
DOWNSTREAM SIGNAL TRANSDUCTION
|
29
|
8.38e-01
|
2.19e-02
|
0.949000
|
EPIGENETIC REGULATION OF GENE EXPRESSION
|
103
|
7.02e-01
|
2.18e-02
|
0.893000
|
TOLL LIKE RECEPTOR 9 TLR9 CASCADE
|
92
|
7.18e-01
|
2.18e-02
|
0.896000
|
INTERLEUKIN 17 SIGNALING
|
66
|
7.62e-01
|
2.15e-02
|
0.912000
|
ENERGY DEPENDENT REGULATION OF MTOR BY LKB1 AMPK
|
28
|
8.44e-01
|
-2.15e-02
|
0.950000
|
INTRACELLULAR SIGNALING BY SECOND MESSENGERS
|
280
|
5.46e-01
|
2.10e-02
|
0.811000
|
SARS COV 2 INFECTION
|
65
|
7.70e-01
|
-2.10e-02
|
0.919000
|
ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS
|
38
|
8.23e-01
|
-2.09e-02
|
0.946000
|
CD28 DEPENDENT PI3K AKT SIGNALING
|
20
|
8.72e-01
|
2.09e-02
|
0.963000
|
RA BIOSYNTHESIS PATHWAY
|
14
|
8.93e-01
|
-2.08e-02
|
0.970000
|
DEFECTS IN COBALAMIN B12 METABOLISM
|
12
|
9.02e-01
|
-2.06e-02
|
0.974000
|
FERTILIZATION
|
12
|
9.02e-01
|
-2.04e-02
|
0.974000
|
SIGNALING BY FGFR4
|
32
|
8.41e-01
|
-2.04e-02
|
0.949000
|
REGULATION OF PLK1 ACTIVITY AT G2 M TRANSITION
|
85
|
7.45e-01
|
-2.04e-02
|
0.903000
|
SENSORY PERCEPTION
|
149
|
6.69e-01
|
2.03e-02
|
0.881000
|
REGULATION OF GLUCOKINASE BY GLUCOKINASE REGULATORY PROTEIN
|
30
|
8.48e-01
|
2.02e-02
|
0.950000
|
RAC3 GTPASE CYCLE
|
88
|
7.50e-01
|
-1.96e-02
|
0.905000
|
TRANSPORT OF MATURE MRNAS DERIVED FROM INTRONLESS TRANSCRIPTS
|
41
|
8.28e-01
|
1.96e-02
|
0.946000
|
TP53 REGULATES TRANSCRIPTION OF CELL DEATH GENES
|
37
|
8.37e-01
|
-1.95e-02
|
0.949000
|
SARS COV INFECTIONS
|
140
|
6.92e-01
|
1.94e-02
|
0.888000
|
MITOCHONDRIAL PROTEIN IMPORT
|
63
|
7.90e-01
|
-1.94e-02
|
0.929000
|
NEGATIVE REGULATION OF FGFR4 SIGNALING
|
22
|
8.77e-01
|
1.91e-02
|
0.965000
|
PTEN REGULATION
|
134
|
7.04e-01
|
-1.90e-02
|
0.895000
|
LYSOSOME VESICLE BIOGENESIS
|
32
|
8.53e-01
|
-1.89e-02
|
0.953000
|
POLYMERASE SWITCHING ON THE C STRAND OF THE TELOMERE
|
25
|
8.71e-01
|
-1.88e-02
|
0.963000
|
G ALPHA Q SIGNALLING EVENTS
|
146
|
6.98e-01
|
-1.86e-02
|
0.891000
|
CIRCADIAN CLOCK
|
68
|
7.91e-01
|
1.86e-02
|
0.929000
|
TRNA MODIFICATION IN THE NUCLEUS AND CYTOSOL
|
43
|
8.34e-01
|
1.85e-02
|
0.949000
|
NUCLEAR PORE COMPLEX NPC DISASSEMBLY
|
32
|
8.57e-01
|
1.84e-02
|
0.956000
|
SYNDECAN INTERACTIONS
|
26
|
8.72e-01
|
1.82e-02
|
0.963000
|
PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS
|
12
|
9.14e-01
|
-1.80e-02
|
0.977000
|
SUMOYLATION OF CHROMATIN ORGANIZATION PROTEINS
|
57
|
8.20e-01
|
-1.74e-02
|
0.946000
|
SEMA3A PAK DEPENDENT AXON REPULSION
|
16
|
9.06e-01
|
1.71e-02
|
0.976000
|
NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY
|
41
|
8.50e-01
|
1.70e-02
|
0.951000
|
RUNX2 REGULATES OSTEOBLAST DIFFERENTIATION
|
23
|
8.89e-01
|
1.69e-02
|
0.967000
|
POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS
|
57
|
8.26e-01
|
1.69e-02
|
0.946000
|
BUDDING AND MATURATION OF HIV VIRION
|
27
|
8.80e-01
|
-1.67e-02
|
0.965000
|
TRAF6 MEDIATED IRF7 ACTIVATION
|
15
|
9.11e-01
|
-1.67e-02
|
0.977000
|
TP53 REGULATES TRANSCRIPTION OF CELL CYCLE GENES
|
45
|
8.47e-01
|
1.66e-02
|
0.950000
|
PEPTIDE LIGAND BINDING RECEPTORS
|
96
|
7.80e-01
|
-1.65e-02
|
0.928000
|
TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR TC NER
|
78
|
8.02e-01
|
-1.65e-02
|
0.932000
|
KSRP KHSRP BINDS AND DESTABILIZES MRNA
|
16
|
9.12e-01
|
1.60e-02
|
0.977000
|
UPTAKE AND ACTIONS OF BACTERIAL TOXINS
|
29
|
8.82e-01
|
-1.59e-02
|
0.965000
|
TOLL LIKE RECEPTOR TLR1 TLR2 CASCADE
|
93
|
7.92e-01
|
1.59e-02
|
0.929000
|
CELL SURFACE INTERACTIONS AT THE VASCULAR WALL
|
90
|
7.95e-01
|
-1.59e-02
|
0.929000
|
RNA POLYMERASE III TRANSCRIPTION
|
41
|
8.61e-01
|
-1.58e-02
|
0.957000
|
PIWI INTERACTING RNA PIRNA BIOGENESIS
|
20
|
9.03e-01
|
-1.57e-02
|
0.974000
|
VISUAL PHOTOTRANSDUCTION
|
60
|
8.35e-01
|
1.56e-02
|
0.949000
|
PKA MEDIATED PHOSPHORYLATION OF CREB
|
19
|
9.07e-01
|
-1.55e-02
|
0.976000
|
GLUTATHIONE CONJUGATION
|
29
|
8.85e-01
|
-1.55e-02
|
0.965000
|
CYTOSOLIC TRNA AMINOACYLATION
|
24
|
8.96e-01
|
-1.54e-02
|
0.972000
|
FLT3 SIGNALING
|
37
|
8.72e-01
|
-1.53e-02
|
0.963000
|
EPHA MEDIATED GROWTH CONE COLLAPSE
|
29
|
8.87e-01
|
-1.52e-02
|
0.967000
|
NUCLEOTIDE EXCISION REPAIR
|
110
|
7.83e-01
|
-1.52e-02
|
0.928000
|
MITOCHONDRIAL FATTY ACID BETA OXIDATION
|
33
|
8.82e-01
|
-1.50e-02
|
0.965000
|
DNA REPAIR
|
292
|
6.62e-01
|
-1.49e-02
|
0.881000
|
NEF MEDIATES DOWN MODULATION OF CELL SURFACE RECEPTORS BY RECRUITING THEM TO CLATHRIN ADAPTERS
|
19
|
9.11e-01
|
-1.49e-02
|
0.977000
|
UNWINDING OF DNA
|
12
|
9.30e-01
|
1.47e-02
|
0.988000
|
TRANSPORT OF THE SLBP DEPENDANT MATURE MRNA
|
34
|
8.84e-01
|
-1.44e-02
|
0.965000
|
GROWTH HORMONE RECEPTOR SIGNALING
|
20
|
9.11e-01
|
1.44e-02
|
0.977000
|
SLC TRANSPORTER DISORDERS
|
74
|
8.30e-01
|
-1.44e-02
|
0.946000
|
DISEASES OF SIGNAL TRANSDUCTION BY GROWTH FACTOR RECEPTORS AND SECOND MESSENGERS
|
364
|
6.40e-01
|
1.43e-02
|
0.867000
|
NUCLEAR ENVELOPE BREAKDOWN
|
49
|
8.63e-01
|
1.43e-02
|
0.958000
|
PRC2 METHYLATES HISTONES AND DNA
|
29
|
8.96e-01
|
-1.40e-02
|
0.972000
|
SUMOYLATION OF UBIQUITINYLATION PROTEINS
|
37
|
8.84e-01
|
-1.39e-02
|
0.965000
|
RHO GTPASE EFFECTORS
|
245
|
7.28e-01
|
1.29e-02
|
0.897000
|
MYD88 INDEPENDENT TLR4 CASCADE
|
94
|
8.30e-01
|
-1.28e-02
|
0.946000
|
BILE ACID AND BILE SALT METABOLISM
|
25
|
9.13e-01
|
1.27e-02
|
0.977000
|
NUCLEAR IMPORT OF REV PROTEIN
|
32
|
9.03e-01
|
-1.25e-02
|
0.974000
|
TRNA PROCESSING IN THE NUCLEUS
|
56
|
8.74e-01
|
-1.23e-02
|
0.963000
|
PROTEIN FOLDING
|
89
|
8.44e-01
|
1.21e-02
|
0.950000
|
REGULATION OF FZD BY UBIQUITINATION
|
19
|
9.29e-01
|
-1.19e-02
|
0.988000
|
CITRIC ACID CYCLE TCA CYCLE
|
22
|
9.29e-01
|
-1.10e-02
|
0.988000
|
SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS
|
11
|
9.51e-01
|
-1.08e-02
|
0.996000
|
POST TRANSLATIONAL PROTEIN MODIFICATION
|
1216
|
5.34e-01
|
-1.07e-02
|
0.810000
|
TRANSLOCATION OF SLC2A4 GLUT4 TO THE PLASMA MEMBRANE
|
63
|
8.85e-01
|
-1.06e-02
|
0.965000
|
P75NTR REGULATES AXONOGENESIS
|
10
|
9.55e-01
|
1.03e-02
|
0.996000
|
AMINO ACIDS REGULATE MTORC1
|
51
|
9.01e-01
|
1.00e-02
|
0.974000
|
SIGNALING BY FGFR2 IIIA TM
|
19
|
9.41e-01
|
9.88e-03
|
0.995000
|
TCF DEPENDENT SIGNALING IN RESPONSE TO WNT
|
177
|
8.21e-01
|
-9.87e-03
|
0.946000
|
NEUROTRANSMITTER RECEPTORS AND POSTSYNAPTIC SIGNAL TRANSMISSION
|
179
|
8.27e-01
|
9.46e-03
|
0.946000
|
ENDOGENOUS STEROLS
|
20
|
9.43e-01
|
-9.28e-03
|
0.995000
|
RETROGRADE TRANSPORT AT THE TRANS GOLGI NETWORK
|
48
|
9.14e-01
|
-9.04e-03
|
0.977000
|
ATF4 ACTIVATES GENES IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS
|
23
|
9.40e-01
|
9.01e-03
|
0.995000
|
MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE
|
15
|
9.52e-01
|
-8.94e-03
|
0.996000
|
INTERLEUKIN 15 SIGNALING
|
12
|
9.58e-01
|
8.69e-03
|
0.996000
|
HS GAG BIOSYNTHESIS
|
29
|
9.36e-01
|
-8.64e-03
|
0.993000
|
DUAL INCISION IN GG NER
|
41
|
9.27e-01
|
-8.29e-03
|
0.988000
|
SUMOYLATION OF IMMUNE RESPONSE PROTEINS
|
11
|
9.66e-01
|
7.46e-03
|
0.996000
|
ALPHA PROTEIN KINASE 1 SIGNALING PATHWAY
|
11
|
9.66e-01
|
-7.43e-03
|
0.996000
|
FGFR2 MUTANT RECEPTOR ACTIVATION
|
26
|
9.49e-01
|
-7.26e-03
|
0.996000
|
RNA POLYMERASE III TRANSCRIPTION INITIATION FROM TYPE 1 PROMOTER
|
28
|
9.47e-01
|
7.26e-03
|
0.996000
|
ZINC INFLUX INTO CELLS BY THE SLC39 GENE FAMILY
|
10
|
9.69e-01
|
-7.12e-03
|
0.997000
|
REGULATION OF TP53 ACTIVITY
|
151
|
8.83e-01
|
6.97e-03
|
0.965000
|
SIALIC ACID METABOLISM
|
32
|
9.46e-01
|
-6.90e-03
|
0.996000
|
RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2
|
107
|
9.02e-01
|
-6.88e-03
|
0.974000
|
WNT LIGAND BIOGENESIS AND TRAFFICKING
|
23
|
9.55e-01
|
6.85e-03
|
0.996000
|
SIGNALING BY FGFR
|
72
|
9.23e-01
|
-6.61e-03
|
0.984000
|
SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI
|
18
|
9.63e-01
|
-6.39e-03
|
0.996000
|
RECRUITMENT OF MITOTIC CENTROSOME PROTEINS AND COMPLEXES
|
78
|
9.22e-01
|
6.39e-03
|
0.984000
|
SIGNALING BY FGFR2
|
62
|
9.34e-01
|
-6.07e-03
|
0.992000
|
ATF6 ATF6 ALPHA ACTIVATES CHAPERONES
|
12
|
9.71e-01
|
6.06e-03
|
0.997000
|
SMOOTH MUSCLE CONTRACTION
|
33
|
9.52e-01
|
-6.05e-03
|
0.996000
|
TELOMERE EXTENSION BY TELOMERASE
|
22
|
9.61e-01
|
6.01e-03
|
0.996000
|
MEIOTIC SYNAPSIS
|
40
|
9.49e-01
|
-5.86e-03
|
0.996000
|
NOTCH4 ACTIVATION AND TRANSMISSION OF SIGNAL TO THE NUCLEUS
|
12
|
9.73e-01
|
5.69e-03
|
0.997000
|
DNA DOUBLE STRAND BREAK REPAIR
|
137
|
9.12e-01
|
-5.46e-03
|
0.977000
|
VITAMIN B5 PANTOTHENATE METABOLISM
|
14
|
9.74e-01
|
-5.07e-03
|
0.997000
|
SIGNALING BY FGFR3
|
35
|
9.59e-01
|
5.01e-03
|
0.996000
|
INFECTION WITH MYCOBACTERIUM TUBERCULOSIS
|
24
|
9.68e-01
|
-4.79e-03
|
0.997000
|
HEDGEHOG ON STATE
|
83
|
9.41e-01
|
4.69e-03
|
0.995000
|
TICAM1 TRAF6 DEPENDENT INDUCTION OF TAK1 COMPLEX
|
11
|
9.79e-01
|
4.68e-03
|
0.997000
|
NEGATIVE REGULATION OF FGFR2 SIGNALING
|
27
|
9.67e-01
|
4.65e-03
|
0.996000
|
GABA B RECEPTOR ACTIVATION
|
39
|
9.60e-01
|
-4.64e-03
|
0.996000
|
SPHINGOLIPID METABOLISM
|
81
|
9.43e-01
|
-4.63e-03
|
0.995000
|
MITOCHONDRIAL BIOGENESIS
|
92
|
9.40e-01
|
4.57e-03
|
0.995000
|
ATF6 ATF6 ALPHA ACTIVATES CHAPERONE GENES
|
10
|
9.80e-01
|
-4.48e-03
|
0.997000
|
NEUROTRANSMITTER RELEASE CYCLE
|
47
|
9.58e-01
|
4.40e-03
|
0.996000
|
CASPASE ACTIVATION VIA EXTRINSIC APOPTOTIC SIGNALLING PATHWAY
|
24
|
9.71e-01
|
4.32e-03
|
0.997000
|
MISCELLANEOUS TRANSPORT AND BINDING EVENTS
|
20
|
9.74e-01
|
4.23e-03
|
0.997000
|
NEGATIVE EPIGENETIC REGULATION OF RRNA EXPRESSION
|
65
|
9.54e-01
|
-4.15e-03
|
0.996000
|
ROS AND RNS PRODUCTION IN PHAGOCYTES
|
28
|
9.70e-01
|
4.09e-03
|
0.997000
|
NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS
|
52
|
9.61e-01
|
-3.89e-03
|
0.996000
|
AURKA ACTIVATION BY TPX2
|
71
|
9.56e-01
|
-3.80e-03
|
0.996000
|
FORMATION OF RNA POL II ELONGATION COMPLEX
|
57
|
9.64e-01
|
3.48e-03
|
0.996000
|
DNA DOUBLE STRAND BREAK RESPONSE
|
52
|
9.66e-01
|
3.44e-03
|
0.996000
|
NEGATIVE REGULATION OF THE PI3K AKT NETWORK
|
92
|
9.56e-01
|
3.35e-03
|
0.996000
|
ESTROGEN DEPENDENT GENE EXPRESSION
|
102
|
9.62e-01
|
-2.72e-03
|
0.996000
|
CELLULAR RESPONSE TO HEAT STRESS
|
96
|
9.65e-01
|
2.57e-03
|
0.996000
|
TRANSCRIPTIONAL REGULATION BY THE AP 2 TFAP2 FAMILY OF TRANSCRIPTION FACTORS
|
29
|
9.82e-01
|
2.45e-03
|
0.997000
|
CONSTITUTIVE SIGNALING BY ABERRANT PI3K IN CANCER
|
60
|
9.75e-01
|
-2.36e-03
|
0.997000
|
RESOLUTION OF ABASIC SITES AP SITES
|
38
|
9.82e-01
|
-2.13e-03
|
0.997000
|
ACYL CHAIN REMODELLING OF PE
|
16
|
9.91e-01
|
-1.65e-03
|
1.000000
|
SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION
|
31
|
9.88e-01
|
-1.58e-03
|
1.000000
|
CARGO RECOGNITION FOR CLATHRIN MEDIATED ENDOCYTOSIS
|
90
|
9.80e-01
|
-1.56e-03
|
0.997000
|
TELOMERE MAINTENANCE
|
78
|
9.82e-01
|
-1.50e-03
|
0.997000
|
DISEASES OF PROGRAMMED CELL DEATH
|
54
|
9.86e-01
|
1.36e-03
|
1.000000
|
CILIUM ASSEMBLY
|
190
|
9.76e-01
|
-1.26e-03
|
0.997000
|
CAMK IV MEDIATED PHOSPHORYLATION OF CREB
|
10
|
9.95e-01
|
1.25e-03
|
1.000000
|
G ALPHA I SIGNALLING EVENTS
|
192
|
9.81e-01
|
-9.94e-04
|
0.997000
|
MET RECEPTOR RECYCLING
|
10
|
9.96e-01
|
9.35e-04
|
1.000000
|
ABERRANT REGULATION OF MITOTIC G1 S TRANSITION IN CANCER DUE TO RB1 DEFECTS
|
17
|
9.95e-01
|
8.98e-04
|
1.000000
|
PYRIMIDINE CATABOLISM
|
10
|
9.97e-01
|
7.93e-04
|
1.000000
|
ORGANELLE BIOGENESIS AND MAINTENANCE
|
282
|
9.85e-01
|
6.55e-04
|
0.999000
|
PCP CE PATHWAY
|
91
|
9.92e-01
|
6.02e-04
|
1.000000
|
MYOGENESIS
|
25
|
9.97e-01
|
4.50e-04
|
1.000000
|
REGULATION OF CHOLESTEROL BIOSYNTHESIS BY SREBP SREBF
|
56
|
9.96e-01
|
-3.88e-04
|
1.000000
|
EXPORT OF VIRAL RIBONUCLEOPROTEINS FROM NUCLEUS
|
31
|
9.98e-01
|
3.06e-04
|
1.000000
|
REGULATION OF GLYCOLYSIS BY FRUCTOSE 2 6 BISPHOSPHATE METABOLISM
|
10
|
9.99e-01
|
2.84e-04
|
1.000000
|
TRANSLATION OF REPLICASE AND ASSEMBLY OF THE REPLICATION TRANSCRIPTION COMPLEX
|
12
|
9.99e-01
|
-2.37e-04
|
1.000000
|
RHOU GTPASE CYCLE
|
33
|
9.99e-01
|
1.62e-04
|
1.000000
|
INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS
|
34
|
9.99e-01
|
-1.36e-04
|
1.000000
|
TRANSCRIPTIONAL REGULATION BY MECP2
|
60
|
9.99e-01
|
-1.27e-04
|
1.000000
|
TRNA PROCESSING
|
105
|
1.00e+00
|
3.40e-06
|
1.000000
|